US20190167139A1 - Subcutaneous P-Wave Centric Insertable Cardiac Monitor For Long Term Electrocardiographic Monitoring - Google Patents
Subcutaneous P-Wave Centric Insertable Cardiac Monitor For Long Term Electrocardiographic Monitoring Download PDFInfo
- Publication number
- US20190167139A1 US20190167139A1 US15/832,385 US201715832385A US2019167139A1 US 20190167139 A1 US20190167139 A1 US 20190167139A1 US 201715832385 A US201715832385 A US 201715832385A US 2019167139 A1 US2019167139 A1 US 2019167139A1
- Authority
- US
- United States
- Prior art keywords
- ecg
- icm
- accordance
- implantable housing
- sensing electrodes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A61B5/0422—
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/25—Bioelectric electrodes therefor
- A61B5/279—Bioelectric electrodes therefor specially adapted for particular uses
- A61B5/28—Bioelectric electrodes therefor specially adapted for particular uses for electrocardiography [ECG]
- A61B5/283—Invasive
- A61B5/287—Holders for multiple electrodes, e.g. electrode catheters for electrophysiological study [EPS]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
- A61B5/0004—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network characterised by the type of physiological signal transmitted
- A61B5/0006—ECG or EEG signals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
- A61B5/0031—Implanted circuitry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/0205—Simultaneously evaluating both cardiovascular conditions and different types of body conditions, e.g. heart and respiratory condition
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/0205—Simultaneously evaluating both cardiovascular conditions and different types of body conditions, e.g. heart and respiratory condition
- A61B5/02055—Simultaneously evaluating both cardiovascular condition and temperature
-
- A61B5/04325—
-
- A61B5/0452—
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/07—Endoradiosondes
- A61B5/076—Permanent implantations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/25—Bioelectric electrodes therefor
- A61B5/279—Bioelectric electrodes therefor specially adapted for particular uses
- A61B5/28—Bioelectric electrodes therefor specially adapted for particular uses for electrocardiography [ECG]
- A61B5/283—Invasive
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/30—Input circuits therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/316—Modalities, i.e. specific diagnostic methods
- A61B5/318—Heart-related electrical modalities, e.g. electrocardiography [ECG]
- A61B5/333—Recording apparatus specially adapted therefor
- A61B5/335—Recording apparatus specially adapted therefor using integrated circuit memory devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/316—Modalities, i.e. specific diagnostic methods
- A61B5/318—Heart-related electrical modalities, e.g. electrocardiography [ECG]
- A61B5/346—Analysis of electrocardiograms
- A61B5/349—Detecting specific parameters of the electrocardiograph cycle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6846—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
- A61B5/6847—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive mounted on an invasive device
- A61B5/686—Permanently implanted devices, e.g. pacemakers, other stimulators, biochips
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/74—Details of notification to user or communication with user or patient ; user input means
- A61B5/746—Alarms related to a physiological condition, e.g. details of setting alarm thresholds or avoiding false alarms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2560/00—Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
- A61B2560/02—Operational features
- A61B2560/0204—Operational features of power management
- A61B2560/0209—Operational features of power management adapted for power saving
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2560/00—Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
- A61B2560/04—Constructional details of apparatus
- A61B2560/0475—Special features of memory means, e.g. removable memory cards
- A61B2560/0481—Special features of memory means, e.g. removable memory cards in implanted apparatus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
- A61B2562/16—Details of sensor housings or probes; Details of structural supports for sensors
- A61B2562/162—Capsule shaped sensor housings, e.g. for swallowing or implantation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/021—Measuring pressure in heart or blood vessels
- A61B5/0215—Measuring pressure in heart or blood vessels by means inserted into the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/08—Detecting, measuring or recording devices for evaluating the respiratory organs
- A61B5/0816—Measuring devices for examining respiratory frequency
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14542—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring blood gases
Definitions
- This application relates in general to electrocardiographic monitoring and, in particular, to a subcutaneous P-wave-centric insertable cardiac monitor (ICM) for long term electrocardiographic monitoring with special emphasis on reliably visualizing the P-wave.
- ICM subcutaneous P-wave-centric insertable cardiac monitor
- ECG electrocardiogram
- Cardiac depolarization which is the spread of electrical current throughout the heart, originates in the sinoatrial (SA) node in the right atrium and spreads leftward towards the left atrium and inferiorly towards the atrioventricular (AV) node. Thereafter a delay, occasioned by the AV node, allows atrial blood to enter the ventricles, prior to the continuation of the depolarization current proceeding down the Bundle of His and into the right and left bundle branches, then advancing to the Purkinje fibers, and finally spreading to activate the right and left ventricular muscle fibers themselves that lead to the heart muscle squeezing the blood supply forward.
- SA sinoatrial
- AV atrioventricular
- the transmembrane ionic currents create an electrical field in and around the heart that can be detected by ECG electrodes either placed on the skin or implanted under the skin of the thorax to record far field electrical signals from the heart.
- These far field electrical signals are the captured ECG signals that can be visually depicted in an ECG trace as the PQRSTU waveforms, each letter of which represents a specific electrical activity in the heart well known to cardiologists.
- these waveforms indicate key aspects of cardiac electrical activity.
- the critical P-wave component of each heartbeat represents atrial electrical activity, the electrical signal that is essential if one is to understand heart rhythm disorders.
- the QRS components represent ventricular electrical activity, equally critical to understanding heart rhythm disorders.
- the TU components represent ventricular cell voltages that are the result of resetting cellular currents in preparation for the next cardiac cycle.
- the TU components are generally of limited value for the purposes of understanding heart rhythm disorders and are rarely addressed in the analysis of heart rhythm disorders per se. (Note that the signals involved in the resetting of the atria are so minuscule as to not be visible in an ECG trace or, even in a standard intra-cardiac recording.)
- the QRS components of the ventricle electrical activity are often termed the “R-wave,” in brief, as a shorthand way of identifying ventricular electrical activity in its entirety.
- R-wave the shorthand version of “R-wave” will be used to indicate ventricular activity
- P-wave the shorthand version of “R-wave” will be used to indicate atrial activity.
- These “waves” represent the two critical components of arrhythmia monitoring and diagnosis performed every day hundreds of thousands of times across the United States. Without a knowledge of the relationship of these two basic symbols, heart rhythm disorders cannot be reliably diagnosed.
- Atrial tachyarrhythmias also known as supraventricular tachyarrhythmias, or SVTs
- VTs ventricular tachyarrhythmias
- bradycardias related to sinus node and atrioventricular (AV) node dysfunction.
- SVTs supraventricular tachyarrhythmias
- VTs ventricular tachyarrhythmias
- bradycardias related to sinus node and atrioventricular (AV) node dysfunction.
- AV atrioventricular
- Subcutaneous ECG monitors because of their small size, have greater problems of demonstrating a clear and dependable P-wave.
- the issues related to a tiny atrial voltage are exacerbated by the small size of insertable cardiac monitors (ICMs), the signal processing limits imposed upon them by virtue of their reduced electrode size, and restricted inter-electrode spacing.
- ICMs insertable cardiac monitors
- Conventional subcutaneous ICMs, as well as most conventional surface ECG monitors are notorious for poor visualization of the P-wave, which remains the primary reason that heart rhythm disorders cannot precisely be identified today from ICMs.
- the P-wave may not actually appear on an ECG because the P-wave's visibility is strongly dependent upon the signal capturing ability of the ECG recording device's sensing circuitry.
- This situation is further influenced by several factors, including electrode configuration, electrode surface areas and shapes, inter-electrode spacing; where the electrodes are placed on or within the body relative to the heart's atria. Further, the presence or absence of ambient noise and the means to limit the ambient noise is a key aspect of whether the low amplitude atrial signal can be seen.
- ICMs are generally capable of monitoring a patient's heart rhythm for up to three years and are often used after diagnostic measures when dermal ECG monitors fail to identify a suspected arrhythmia. Consequently, when a physician is strongly suspicious of a serious cardiac rhythm disorder that may have caused loss of consciousness or stroke, for example, the physician will often proceed to the insertion of an ICM under the skin of the thorax. Although traditionally, the quality of the signal is limited with ICMs with respect to identifying the P-wave, the duration of monitoring is hoped to compensate for poor P-wave recording.
- the P-wave is the most difficult ECG signal to capture by virtue of originating in the low tissue mass atria and having both low voltage amplitude and relatively low frequency content.
- ICMs are popular, albeit limited in their diagnostic yield.
- the current realm of ICM devices use a loop recorder where cumulative ECG data lasting for around an hour is continually overwritten unless an episode of pre-programmed interest occurs or a patient marker is manually triggered.
- the limited temporal window afforded by the recordation loop is yet another restriction on the evaluation of the P-wave, and related cardiac morphologies, and further compromises diagnostic opportunities.
- Medtronic's Reveal LINQ ICM delivers long-term subcutaneous ECG monitoring for up to three years, depending on programming.
- the monitor is able to store up to 59 minutes of ECG data, include up to 30 minutes of patient-activated episodes, 27 minutes of automatically detected episodes, and two minutes of the longest atrial fibrillation (AF) episode stored since the last interrogation of the device.
- the focus of the device is more directed to recording duration and programming options for recording time and patient interactions rather than signal fidelity.
- the Reveal LINQ ICM is intended for general purpose ECG monitoring and lacks an engineering focus on P-wave visualization.
- the device's recording circuitry is intended to secure the ventricular signal by capturing the R-wave, and is designed to accommodate placement over a broad range of subcutaneous implantation sites, which is usually sufficient if one is focused on the R-wave given its amplitude and frequency content, but of limited value in capturing the low-amplitude, low-frequency content P-wave.
- electrode spacing, surface areas, and shapes are dictated (and limited) by the physical size of the monitor's housing which is quite small, an aesthetic choice, but unrealistic with respect to capturing the P-wave.
- a need remains for a continuously recording long-term ICM particularly attuned to capturing low amplitude cardiac action potential propagation from the atria, that is, the P-wave, for accurate arrhythmia event capture and subsequent diagnosis.
- ICM subcutaneous insertable cardiac monitor
- One embodiment provides a P-wave centric subcutaneous insertable cardiac monitor for use in performing long term electrocardiographic (ECG) monitoring.
- An implantable housing made of a biocompatible material that is suitable for implantation within a living body is provided.
- At least one pair of ECG sensing electrodes is provided on a ventral (or dorsal) surface and on opposite ends of the implantable housing operatively placed to facilitate sensing in closest proximity to the low amplitude, low frequency content cardiac action potentials that are generated during atrial activation.
- Electronic circuitry is provided within the housing assembly including a low power microcontroller operable to execute under modular micro program control as specified in firmware, an ECG front end circuit interfaced to the microcontroller and configured to capture the cardiac action potentials sensed by the pair of ECG sensing electrodes which are output as ECG signals, and non-volatile memory electrically interfaced with the microcontroller and operable to continuously store samples of the ECG signals.
- FIG. 1 is a diagram showing, by way of example, a subcutaneous P-wave centric insertable cardiac monitor (ICM) for long term electrocardiographic monitoring in accordance with one embodiment.
- ICM subcutaneous P-wave centric insertable cardiac monitor
- FIGS. 2 and 3 are respectively top and bottom perspective views showing the ICM of FIG. 1 .
- FIG. 4 is a bottom perspective view showing the ICM of FIG. 1 in accordance with a further embodiment.
- FIGS. 5 and 6 are respectively top and bottom perspective views showing an ICM in accordance with a still further embodiment.
- FIG. 7 is a plan view showing further electrode configurations.
- FIG. 8 is a functional block diagram showing the P-wave focused component architecture of the circuitry of the ICM of FIG. 1 .
- FIG. 9 is a functional block diagram showing a system for wirelessly interfacing with an ICM in accordance with one embodiment.
- FIG. 10 is a flow diagram showing an ICM-implemented method for monitoring ECG data.
- FIG. 11 is a functional block diagram showing the signal processing functionality of the microcontroller.
- FIG. 12 is a functional block diagram showing the operations performed by the download station.
- FIG. 1 is a diagram showing, by way of example, a subcutaneous P-wave centric ICM 12 for long term electrocardiographic monitoring in accordance with one embodiment.
- the ICM 12 is implanted in the parasternal region 11 of a patient 10 .
- the sensing circuitry and components, compression algorithms, and the physical layout of the electrodes are specifically optimized to capture electrical signals from the propagation of low amplitude, relatively low frequency content cardiac action potentials, particularly the P-waves generated during atrial activation.
- the position and placement of the ICM 12 coupled to engineering considerations that optimize the ICM's sensing circuitry, discussed infra, aid in demonstrating the P-wave clearly.
- Implantation of a P-wave centric ICM 12 in the proper subcutaneous site facilitates the recording of high quality ECG data with a good delineation of the P-wave.
- the ICM 12 is intended to be implanted anteriorly and be positioned axially and slightly to either the right or left of the sternal midline in the parasternal region 11 of the chest, or if sufficient subcutaneous fat exists, directly over the sternum.
- the ICM 12 is implanted in a location left parasternally to bridge the left atrial appendage.
- either location to the right or left of the sternal midline is acceptable; placement of the device, if possible, should bridge the vertical height of the heart, which lies underneath the sternum 7 , thereby placing the ICM 12 in close proximity to the anterior right atrium and the left atrial appendage that lie immediately beneath.
- the ICM 12 is shaped to fit comfortably within the body under the skin and to conform to the contours of the patient's parasternal region 11 when implanted immediately to either side of the sternum 7 , but could be implanted in other locations of the body.
- the proximal end 13 of the ICM 12 is generally positioned below the manubrium 8 but, depending upon patient's vertical build, the ICM 12 may actually straddle the region over the manubrium 8 .
- the distal end 14 of the ICM 12 generally extends towards the xiphoid process 9 and lower sternum but, depending upon the patient's build, may actually straddle the region over or under the xiphoid process 9 , lower sternum and upper abdomen.
- subsurface low amplitude cardiac action potentials particularly P-wave signals with a normative amplitude of less than 0.25 millivolts (mV) and a normative duration of less than 120 milliseconds (ms) are most apt to be negatively impacted by these factors.
- the atria which generate the P wave, are mostly located posteriorly within the thoracic cavity (with the exception of the anterior right atrium, right atrial appendage and left atrial appendage).
- the majority of the left atrium constitutes the portion of the heart furthest away from the surface of the skin on the chest and harbors the atrial tissue most likely to be the source of serious arrhythmias, like atrial fibrillation.
- the ventricles which generate larger amplitude signals, are located anteriorly as in the case of the anterior right ventricle and most of the anterior left ventricle situated relatively close to the skin surface of the central and left anterior chest.
- both the P-wave and the R-wave are required for the physician to make a proper rhythm diagnosis from the dozens of arrhythmias that can occur.
- the quality of P-waves is more susceptible to weakening from distance and the intervening tissues and structures and from signal attenuation and signal processing than the high voltage waveforms associated with ventricular activation.
- the added value of avoiding further signal attenuation resulting from dermal impedance makes a subcutaneous P-wave centric ICM even more likely to match, or even outperform dermal ambulatory monitors designed to analogous engineering considerations and using similar sensing circuitry and components, compression algorithms, and physical layout of electrodes, such as described in U.S. Pat. No. 9,545,204, issued Jan.
- the ICM 12 can be implanted in the patient's chest using, for instance, a minimally invasive subcutaneous implantation instrument or other suitable surgical implement.
- the ICM 12 is positioned slightly to the right or left of midline, covering the center third of the chest, roughly between the second and sixth ribs, approximately spanning between the level of the manubrium 8 and the level of the xiphoid process 9 on the inferior border of the sternum 7 , depending upon the vertical build of the patient 10 .
- an ECG devices including dermal ECG monitors and ICMs
- cardiac, cellular, extracellular, vector of current flow, and physical factors like obesity, dermatitis, lung disease, large breasts, and high impedance skin, as can occur in dark-skinned individuals.
- Performing ECG sensing subcutaneously in the parasternal region 11 significantly improves the ability of the ICM 12 to counter some of the effects of these factors, particularly high skin impedance and impedance from subcutaneous fat.
- the ICM 12 exhibits superior performance when compared to conventional dermal ECG monitors to existing implantable loop recorders, ICMs, and other forms of implantable monitoring devices by virtue of its engineering and proven P-wave documentation above the skin, as discussed in W. M. Smith et al., “Comparison of diagnostic value using a small, single channel, P-wave centric sternal ECG monitoring patch with a standard 3-lead Holter system over 24 hours,” Am. Heart J., March 2017; 185:67-73, the disclosure of which is incorporated by reference.
- the sternal midline implantation location in the parasternal region 11 allows the ICM's electrodes to record an ECG of optimal signal quality from a location immediately above the strongest signal-generating aspects of the atrial. Signal quality is improved further in part because cardiac action potential propagation travels simultaneously along a north-to-south and right-to-left vector, beginning high in the right atrium and ultimately ending in the posterior and lateral region of the left ventricle. Cardiac depolarization originates high in the right atrium in the SA node before concurrently spreading leftward towards the left atrium and inferiorly towards the atrioventricular (AV) node.
- AV atrioventricular
- the ECG electrodes of the ICM 12 are subcutaneously positioned with the upper or superior pole (ECG electrode) slightly to the right or left of the sternal midline in the region of the manubrium 8 and, on the distal end 14 , the lower or inferior pole (ECG electrode) is similarly situated slightly to the right or left of the sternal midline in the region of the xiphoid process 9 and lower sternum 7 .
- the ECG electrodes of the ICM 12 are placed primarily in a north-to-south orientation along the sternum 7 that corresponds to the north-to-south waveform vector exhibited during atrial activation.
- This orientation corresponds to the aVF lead used in a conventional 12-lead ECG that is used to sense positive or upright P-waves.
- the electrode spacing and the electrodes' shapes and surface areas mimic the electrodes used in the ICM's dermal cousin, designed as part of the optimal P-wave sensing electrode configuration, such as provided with the dermal ambulatory monitors cited supra.
- FIGS. 2 and 3 are respectively top and bottom perspective views showing the ICM 12 of FIG. 1 .
- the ICM 12 is constructed with a hermetically sealed implantable housing 15 with at least one ECG electrode forming a superior pole on the proximal end 13 and at least one ECG electrode forming an inferior pole on the distal end 14 .
- the housing 15 When implanted, the housing 15 is oriented most cephalad.
- the housing 15 is constructed of titanium, stainless steel or other biocompatible material.
- the housing 15 contains the sensing, recordation and interfacing circuitry of the ICM 12 , plus a long life battery.
- a wireless antenna is integrated into or within the housing 15 and can be positioned to wrap around the housing's internal periphery or location suited to signal reception. Other wireless antenna placement or integrations are possible.
- the ICM 12 has four ECG electrodes 16 , 17 , 18 , 19 . There could also be additional ECG electrodes, as discussed infra.
- the ECG electrodes include two ventral (or dorsal) ECG electrodes 18 , 19 and two wraparound ECG electrodes 16 , 17 .
- One ventral ECG electrode 18 is formed on the proximal end 13 and one ventral ECG electrode 19 is formed on the distal end 14 .
- One wraparound ECG electrode 16 is formed circumferentially about the proximal end 13 and one wraparound ECG electrode 17 is formed circumferentially about the distal end 14 .
- Each wraparound ECG electrode 16 , 17 is electrically insulated from its respective ventral ECG electrode 18 , 19 by a periphery 20 , 21 .
- the four ECG electrodes 16 , 17 , 18 , 19 are programmatically controlled by a microcontroller through onboard firmware programming to enable a physician to choose from several different electrode configurations that vary the electrode surface areas, shapes, and inter-electrode spacing.
- the sensing circuitry can be programmed, either pre-implant or in situ, to use different combinations of the available ECG electrodes (and thereby changing electrode surface areas, shapes, and inter-electrode spacing), including pairing the two ventral ECG electrodes 16 , 17 , the two wraparound ECG electrodes 18 , 19 , or one ventral ECG electrode 16 , 17 with one wraparound ECG electrode 18 , 19 located on the opposite end of the housing 15 .
- the periphery 20 , 21 can be programmatically controlled to logically combine the wraparound ECG electrode 16 , 17 on one end of the ICM 12 with its corresponding ventral ECG electrode 18 , 19 to form a single virtual ECG electrode with larger surface area and shape.
- the two ECG electrodes that are only on one end of the ICM 12 for instance, wraparound ECG electrode 16 and ventral ECG electrode 18 , could be paired; however, the minimal inter-electrode spacing would likely yield a signal of poor fidelity in most situations.
- the housing 15 and contained circuitry can be provided as a standalone ICM core assembly to which a pair of compatible ECG electrodes can be operatively coupled to form a full implantable ICM device.
- FIG. 4 is a bottom perspective view showing the ICM 12 of FIG. 1 in accordance with a further embodiment.
- An additional pair of ventral ECG electrodes 22 , 23 are included on the housing's ventral surface.
- ventral ECG electrodes 22 , 23 are spaced closer together than the ventral ECG electrodes 18 , 19 on the ends of the housing 15 and a physician can thus choose to pair the two inner ventral ECG electrodes 22 , 23 by themselves to allow for minimal electrode-to-electrode spacing, or with the other ECG electrodes 16 , 17 , 18 , 19 to vary electrode surface areas, shapes, and inter-electrode spacing even further to explore optimal configurations to acquire the P-wave.
- FIGS. 5 and 6 are respectively top and bottom perspective views showing an ICM 30 in accordance with a still further embodiment.
- the ICM 30 has a housing 31 with a tapered extension 32 that is terminated on the distal end with an electrode 34 .
- the housing 31 includes a pair of ECG electrodes electrically insulated by a periphery 37 that include a ventral ECG electrode 33 and a wraparound ECG electrode 34 .
- a ventral ECG electrode 36 is oriented on the housing's distal end before the tapered extension 32 .
- Still other housing structures and electrode configurations are possible.
- the basic electrode layout is sufficient to sense cardiac action potentials in a wide range of patients. Differences in thoracic tissue density and skeletal structure from patient to patient, though, can affect the ability of the sensing electrodes to efficaciously capture action potential signals, yet the degree to which signal acquisition is affected may not be apparent until after an ICM has been implanted and deployed, when the impacts of the patient's physical constitution and his patterns of mobility and physical movement on ICM monitoring can be fully assessed.
- the electrodes can be configured post-implant to allow the ICM to better adapt to a particular patient's physiology.
- electrode configurations having more than two sensing electrodes are possible.
- FIG. 7 is a plan view showing further electrode configurations. Referring first to FIG. 7( a ) , a single disc ECG electrode 40 could be bifurcated to form a pair of half-circle ECG electrodes 41 , 42 that could be programmatically selected or combined to accommodate a particular patients ECG signal characteristics post-ICM implant. Referring next to FIG.
- a single disc ECG electrode 45 could be divided into three sections, a pair of crescent-shaped ECG electrodes 46 , 47 surrounding a central semicircular ECG electrode 48 that could similarly be programmatically selected or combined. Still other ECG electrode configurations are possible.
- FIG. 8 is a functional block diagram showing the P-wave focused component architecture of the circuitry 80 of the ICM 12 of FIG. 1 .
- the circuitry 80 is powered through the long life battery 21 provided in the housing 15 .
- Operation of the circuitry 80 of the ICM 12 is managed by a microcontroller 81 , such as the EFM32 Tiny Gecko 32-bit microcontroller, manufactured by Silicon Laboratories Inc., Austin, Tex.
- the microcontroller 81 has flexible energy management modes and includes a direct memory access controller and built-in analog-to-digital and digital-to-analog converters (ADC and DAC, respectively).
- the microcontroller 81 also includes a program memory unit containing internal flash memory (not shown) that is readable, writeable, and externally programmable.
- the microcontroller 81 operates under modular micro program control as specified in firmware stored in the internal flash memory. The functionality and firmware modules relating to signal processing by the microcontroller 81 are further described infra with reference to FIG. 11 .
- the microcontroller 81 draws power from the battery provided in the housing 15 and connects to the ECG front end circuit 83 .
- the front end circuit 83 measures raw dermal electrical signals using a driven reference signal that eliminates common mode noise, as further described infra.
- the circuitry 80 of the ICM 12 also includes a flash memory 82 external to the microcontroller 81 , which the microcontroller 81 uses for continuously storing samples of ECG monitoring signal data and other physiology, such as respiratory rate, blood oxygen saturation level (SpO 2 ), blood pressure, temperature sensor, and physical activity, and device and related information.
- the flash memory 82 also draws power from the battery provided in the housing 15 . Data is stored in a serial flash memory circuit, which supports read, erase and program operations over a communications bus.
- the flash memory 82 enables the microcontroller 81 to store digitized ECG data.
- the communications bus further enables the flash memory 82 to be directly accessed wirelessly through a transceiver 85 coupled to an antenna 17 built into (or provided with) the housing 15 , as further described infra with reference to FIG. 9 .
- the transceiver 85 can be used for wirelessly interfacing over Bluetooth or other types of wireless technologies for exchanging data over a short distance with a paired mobile device, including smartphones and smart watches, that are designed to communicate over a public communications infrastructure, such as a cellular communications network, and, in a further embodiment, other wearable (or implantable) physiology monitors, such as activity trackers worn on the wrist or body. Other types of device pairings are possible, including with a desktop computer or purpose-built bedside monitor.
- the transceiver 85 can be used to offload stored ECG monitoring data and other physiology data and information and for device firmware reprogramming.
- the flash memory 82 can be accessed through an inductive coupling (not shown).
- the microcontroller 81 includes functionality that enables the acquisition of samples of analog ECG signals, which are converted into a digital representation, as further described infra with reference to FIG. 11 .
- the microcontroller 81 implements a loop recorder feature that will acquire, sample, digitize, signal process, and store digitized ECG data into available storage locations in the flash memory 82 until all memory storage locations are filled, after which existing stored digitized ECG data will either be overwritten through a sliding window protocol, albeit at the cost of potentially losing the stored data that was overwritten, if not previously downloaded, or transmitted wirelessly to an external receiver to unburden the flash memory.
- the stored digitized ECG data can be maintained permanently until downloaded or erased to restore memory capacity. Data download or erasure can also occur before all storage locations are filled, which would free up memory space sooner, albeit at the cost of possibly interrupting monitoring while downloading or erasure is performed. Still other modes of data storage and capacity recovery are possible.
- the circuitry 80 of the ICM 12 can include functionality to programmatically select pairings of sensing electrodes when the ICM 12 is furnished with three or more electrodes.
- multiple sensing electrodes could be provided on the ICM 12 to provide a physician the option of fine-tuning the sensing dipole (or tripole or multipole) in situ by parking active electrodes and designating any remaining electrodes inert.
- the pairing selection can be made remotely through an inductive coupling or by the transceiver 85 via, for instance, a paired mobile device, as further described infra.
- the sensing electrode configuration including number of electrodes, electrode-to-electrode spacing, and electrode size, shape, surface area, and placement, can be modified at any time during the implantation of the ICM 12 .
- the circuitry 80 of the ICM 12 can include an actigraphy sensor 84 implemented as a 3 -axis accelerometer.
- the accelerometer may be configured to generate interrupt signals to the microcontroller 81 by independent initial wake up and free fall events, as well as by device position.
- the actigraphy provided by the accelerometer can be used during post-monitoring analysis to correct the orientation of the ICM 12 if, for instance, the ICM 12 has been inadvertently implanted upside down, that is, with the ICM's housing oriented caudally, as well as for other event occurrence analyses.
- the circuitry 80 of the ICM 12 can include one or more physiology sensors.
- a physiology sensor can be provided as part of the circuitry 80 of the ICM 12 , or can be provided on the electrode assembly 14 with communication with the microcontroller 81 provided through a circuit trace.
- the physiology sensor can include an SpO 2 sensor, blood pressure sensor, temperature sensor, respiratory rate sensor, glucose sensor, airflow sensor, volumetric pressure sensing, or other types of sensor or telemetric input sources.
- firmware with programming instructions can be downloaded into the microcontroller's internal flash memory.
- the firmware can include heuristics to signal patient and physician with alerts over health conditions or arrhythmias of selected medical concern, such as where a heart pattern particular to the patient is identified and the ICM 12 is thereby reprogrammed to watch for a reoccurrence of that pattern, after which an alert will be generated and sent to the physician (or other caregiver) through the transceiver 85 via, for instance, a paired mobile device.
- the firmware can include heuristics that can be downloaded to the ICM 12 to actively identify or narrow down a pattern (or even the underlying cause) of sporadic cardiac conditions, for instance, atrial tachycardia (AT), atrial fibrillation (AF), atrial flutter (AFL), AV node reciprocating tachycardia, ventricular tachycardia (VT), sinus bradycardia, asystole, complete heart block, and other cardiac arrhythmias, again, after which an alert will be generated and sent to the physician (or other caregiver) through the transceiver 85 .
- AT atrial tachycardia
- AF atrial fibrillation
- AFL atrial flutter
- AV node reciprocating tachycardia ventricular tachycardia
- VT ventricular tachycardia
- sinus bradycardia asystole
- complete heart block complete heart block
- other cardiac arrhythmias again, after which an alert will be generated
- an alert that includes a compressed ECG digitized sample can also be wirelessly transmitted by the ICM 12 upon the triggering of a preset condition, such as an abnormally low heart rate in excess of 170 beats per minute (bpm), an abnormally low heart rate falling below 30 bpm, or AF detected by onboard analysis of RR interval variability by the microcontroller 61 .
- a preset condition such as an abnormally low heart rate in excess of 170 beats per minute (bpm), an abnormally low heart rate falling below 30 bpm, or AF detected by onboard analysis of RR interval variability by the microcontroller 61 .
- a similar methodology of creating firmware programming tailored to the monitoring and medical diagnostic needs of a specific patient can be used for other conditions or symptoms, such as syncope, palpitations, dizziness and giddiness, unspecified convulsions, abnormal ECG, transient cerebral ischemic attacks and related syndromes, cerebral infarction, occlusion and stenosis of pre-cerebral and cerebral arteries not resulting in cerebral infarction personal history of transient ischemic attack, and cerebral infarction without residual deficits, to trigger an alert and involve the physician or initiate automated analysis and follow up back at the patient's clinic.
- the circuitry 80 of the ICM 12 can accommodate patient-interfaceable components, including an external tactile feedback device (not shown) that wirelessly interfaces to the ICM 12 through the transceiver 85 .
- a patient 10 can press the external tactile feedback device to mark events, such as a syncope episode, or to perform other functions.
- the circuitry 80 can also accommodate triggering an external buzzer 67 , such as a speaker, magnetic resonator or piezoelectric buzzer, implemented as part of the external tactile feedback device or as a separate wirelessly-interfaceable component.
- the buzzer 67 can be used by the microcontroller 81 to indirectly output feedback to a patient 10 , such as a low battery or other error condition or warning.
- Still other components, provided as either part of the circuitry 80 of the ICM 12 or as external wirelessly-interfaceable devices, are possible.
- the ECG front end circuit 83 of the ICM 12 measures raw dermal electrical signals using a driven reference signal, such as described in U.S. Pat. Nos. 9,700,227, 9,717,433, and 9,615,763, cited supra.
- the driven reference signal effectively reduces common mode noise, power supply noise and system noise, which is critical to preserving the characteristics of low amplitude cardiac action potentials, especially the P wave signals originating from the atria.
- the ECG front end circuit 83 is organized into a passive input filter stage, a unity gain voltage follower stage, a passive high pass filtering stage, a voltage amplification and active filtering stage, and an anti-aliasing passive filter stage, plus a reference generator.
- the passive input filter stage passively shifts the frequency response poles downward to counter the high electrode impedance from the patient on the signal lead and reference lead, which reduces high frequency noise.
- the unity gain voltage follower stage allows the circuit to accommodate a very high input impedance, so as not to disrupt the subcutaneous potentials or the filtering effect of the previous stage.
- the passive high pass filtering stage includes a high pass filter that removes baseline wander and any offset generated from the previous stage.
- the voltage amplification and active filtering stage amplifies or de-amplifies (or allows to pass-through) the voltage of the input signal, while applying a low pass filter.
- the anti-aliasing passive filter stage 75 provides an anti-aliasing low pass filter.
- the reference generator drives a driven reference signal containing power supply noise and system noise to the reference lead and is connected directly to the patient, thereby avoiding the thermal noise of the protection resistor that is included as part of the protection circuit 72 .
- FIG. 9 is a functional block diagram showing a system 90 for wirelessly interfacing with an ICM 12 in accordance with one embodiment.
- the ICM 12 is designed for long-term electrocardiographic and physiological monitoring lasting up to several years in duration. During that time, stored data ECG monitoring data and other physiology and information will need to be offloaded and the ICM's firmware may need to be reprogrammed, and the transceiver 85 enables the ICM 12 to communicate with external devices to facilitate these functions.
- the ICM 12 can be wirelessly connected to a download station 92 executing data link software (“DL”) 93 that permits the secure remote retrieval of stored ECG monitoring data, execution of diagnostics on or programming of the ICM 12 , or performance of other functions.
- the ICM 12 connects to the download station 92 over a wireless network 91 via the transceiver 85 .
- the download station 92 executes the data link software 93 or similar program that wirelessly interacts with the ICM 12 to retrieve the stored ECG monitoring data or perform other function.
- the download station 92 could be a server, personal computer, tablet or handheld computer, smart mobile device, or purpose-built programmer designed specific to the task of interfacing with a ICM 12 . Still other forms of download station 92 are possible.
- middleware executing on the download station 92 first operates on the retrieved data to adjust the ECG capture quality, as necessary, and to convert the retrieved data into a format suitable for use by third party post-monitoring analysis software, as further described infra with reference to FIG. 12 .
- the formatted data can then be retrieved from the download station 92 .
- the middleware could alternatively be executed by a separate device other than the download station 92 .
- a client-server model could be used to employ a server 94 to remotely interface with the download station 92 over the network 91 and retrieve the formatted data or other information.
- the server 94 executes a patient management program 95 (“Mgt”) or similar application that stores the retrieved formatted data, recorded physiology, and other information in a secure database 96 cataloged in that patient's electronic medical records (EMRs) 97 , along with tracking and correlating patient symptoms.
- EMRs electronic medical records
- the patient management program 95 could manage a subscription service that authorizes a ICM 12 to operate for a set period of time or under pre-defined operational parameters.
- the patient management program 95 also maintains and safeguards the secure database 96 to limit access to patient EMRs 97 to only authorized parties for appropriate medical or other uses, such as mandated by state or federal law, such as under the Health Insurance Portability and Accountability Act (HIPAA) or per the European Union's Data Protection Directive.
- HIPAA Health Insurance Portability and Accountability Act
- a physician may seek to review and evaluate his patient's ECG monitoring data, as securely stored in the secure database 96 .
- Physician and other authorized healthcare personnel are able to securely access the retrieved formatted data and other information stored in the EMRs 97 in the secure database 96 by executing an application program (“MD”) 98 , such as a post-monitoring ECG analysis program, on a personal computer 99 or other connectable computing device, and, through the application program 98 , coordinate access to his patient's EMRs 97 with the patient management program 95 and perform other functions.
- MD application program
- the application program 98 can include the capability to actively or interactively diagnose or narrow down the underlying cause of sporadic cardiac conditions, for instance, atrial tachycardia (AT), AF, atrial flutter, AV node reciprocating tachycardia, ventricular tachycardia (VT), sinus bradycardia, asystole, complete heart block, and other cardiac arrhythmias. Other diagnoses are possible.
- AT atrial tachycardia
- AF atrial tachycardia
- AV node reciprocating tachycardia ventricular tachycardia
- VT ventricular tachycardia
- sinus bradycardia asystole
- complete heart block and other cardiac arrhythmias.
- Other diagnoses are possible.
- RR interval data can be extracted from the retrieved formatted data and be presented to physicians in a format that includes views of relevant near field and far field ECG data, which together provide contextual information that improves diagnostic accuracy, such as described in U.S. Pat. No. 9,408,551, issued Aug. 9, 2016 to Bardy et al., the disclosure of which is incorporated by reference.
- Both near field and far field ECG data views are temporally keyed to an extended duration RR interval data view.
- the durations of the classical “pinpoint” view, the pre- and post-event “intermediate” view, and the RR interval plot are flexible and adjustable.
- the pinpoint “snapshot” and intermediate views of ECG data with the extended term RR interval data allow a physician to comparatively view heart rate context and patterns of behavior prior to and after a clinically meaningful arrhythmia, patient concern or other indicia, thereby enhancing diagnostic specificity of cardiac rhythm disorders and providing physiological context to improve diagnostic ability.
- a complete end-to-end closed loop of patient care can be provided, with the ICM 12 providing long-term ECG and physiology monitoring and data reporting, the patient management program 95 managing ECG and physiology data retrieval and patient symptom tracking and correlation, the application program 98 empowering physicians with the ability to effectively identify the underlying cause of sporadic cardiac conditions, particularly cardiac rhythm disorders, and the ICM 12 again facilitating patient following upon diagnosis and throughout treatment.
- the ICM 12 can interoperate wirelessly with other physiology monitors and activity sensors 104 , whether implanted or dermal, such as activity trackers worn on the wrist or body, and with mobile devices 102 , including smartphones and smart watches, that are designed to communicate over a public communications infrastructure, such as a cellular communications network.
- Wearable physiology monitors and activity sensors 104 encompass a wide range of wirelessly interconnectable devices that measure or monitor a patient's physiological data, such as heart rate, temperature, blood pressure, respiratory rate, blood pressure, blood sugar (with appropriate subcutaneous probe), oxygen saturation, minute ventilation, and so on; physical states, such as movement, sleep, footsteps, and the like; and performance, including calories burned or estimated blood glucose level.
- the physiology sensors in non-wearable mobile devices 102 are generally not meant for continuous tracking and do not provide medically precise and actionable data sufficient for a physician to prescribe a surgical, catheter or serious drug intervention; such data can be considered screening information that something may be wrong, but not data that provides the highly precise information that may allow for a surgery, such as implantation of a pacemaker for heart block or a defibrillator for ventricular tachycardia, or the application of serious medications, like blood thinners for atrial fibrillation or a cardiac ablation procedure.
- Such devices like smartphones, are better suited to pre- and post-exercise monitoring or as devices that can provide a signal that something is wrong, but not in the sufficient detail and FDA approved, legally meaningful validation to allow for medical action.
- medically actionable wearable sensors and devices sometimes provide continuous recording for relatively short time periods, up to 80 days, but do not span years and, further, must be paired with a smartphone or computer to offload and evaluate the recorded data, especially if the data is of urgent concern.
- Wearable physiology monitors and activity sensors 104 also known as “activity monitors,” and to a lesser extent, “fitness” sensor-equipped mobile devices 102 , can trace their life-tracking origins to ambulatory devices used within the medical community to sense and record traditional medical physiology that could be useful to a physician in arriving at a patient diagnosis or clinical trajectory, as well as from outside the medical community, from, for instance, sports or lifestyle product companies who seek to educate and assist individuals with self-quantifying interests. Data is typically tracked by the wearable physiology monitors or activity sensors 104 and mobile device 102 for only the personal use of the wearer. The physiological monitoring is strictly informational, even where a device originated within the medical community, and the data is generally not time-correlated to physician-supervised monitoring.
- cardiac rhythm disorders including tachyarrhythmias, like ventricular tachycardia or atrial fibrillation, and bradyarrhythmias, like heart block
- tachyarrhythmias like ventricular tachycardia or atrial fibrillation
- bradyarrhythmias like heart block
- wearable physiology monitors and activity sensors 104 are capable of wirelessly interfacing with mobile devices 102 , particularly smart mobile devices, including so-called “smartphones” and “smart watches,” as well as with personal computers and tablet or handheld computers, to download monitoring data either in real-time or in batches.
- the wireless interfacing of such activity monitors is generally achieved using transceivers that provide low-power, short-range wireless communications, such as Bluetooth, although some wearable physiology monitors and activity sensors 104 , like their mobile device cohorts, have transceivers that provide true wireless communications services, including 4G or better mobile telecommunications, over a telecommunications network.
- Other types of wireless and wired interfacing are possible.
- the mobile device 102 executes an application (“App”) 103 that can retrieve the data collected by the wearable physiology monitor and activity sensor 104 and evaluate the data to generate information of interest to the wearer, such as an estimation of the effectiveness of the wearer's exercise efforts.
- App an application
- the wearable physiology monitors and activity sensors 104 has sufficient onboard computational resources, the activity monitor itself executes an app without the need to relay data to a mobile device 102 .
- the app can include or be supplemented by downloadable programming instructions, including machine learning and other forms of artificial intelligence-originated instructions.
- the app can include heuristics to signal patient and physician with alerts over health conditions or arrhythmias of selected medical concern, such as where a heart pattern particular to the patient is identified and the mobile device 102 , in collaboration with the ICM 12 , is thereby reprogrammed to watch for a reoccurrence of that pattern, after which an alert will be generated and sent to the physician (or other caregiver).
- the app can include heuristics that can actively identify or narrow down a pattern (or even the underlying cause) of sporadic cardiac conditions, for instance, atrial tachycardia (AT), atrial fibrillation (AF), atrial flutter (AFL), AV node reciprocating tachycardia, ventricular tachycardia (VT), sinus bradycardia, asystole, complete heart block, and other cardiac arrhythmias, again, after which an alert will be generated and sent to the physician (or other caregiver).
- AT atrial tachycardia
- AF atrial fibrillation
- AFL atrial flutter
- AV node reciprocating tachycardia ventricular tachycardia
- VT ventricular tachycardia
- sinus bradycardia asystole
- complete heart block and other cardiac arrhythmias
- an alert that includes a compressed ECG digitized sample can also be wirelessly transmitted by the app upon the triggering of a preset condition, such as an abnormally low heart rate in excess of 170 beats per minute (bpm), an abnormally low heart rate falling below 30 bpm, or AF detected by onboard analysis of RR interval variability by the app.
- a preset condition such as an abnormally low heart rate in excess of 170 beats per minute (bpm), an abnormally low heart rate falling below 30 bpm, or AF detected by onboard analysis of RR interval variability by the app.
- a similar methodology of creating app programming tailored to the monitoring and medical diagnostic needs of a specific patient can be used for other conditions or symptoms, such as syncope, palpitations, dizziness and giddiness, unspecified convulsions, abnormal ECG, transient cerebral ischemic attacks and related syndromes, cerebral infarction, occlusion and stenosis of pre-cerebral and cerebral arteries not resulting in cerebral infarction personal history of transient ischemic attack, and cerebral infarction without residual deficits, to trigger an alert and involve the physician or initiate automated analysis and follow up back at the patient's clinic. Still other activity monitor and mobile device functions on the collected data are possible.
- a wearable physiology monitor, activity sensor 104 , or mobile device 102 worn or held by the patient 10 , or otherwise be used proximal to the patient's body can be used to first obtain and then work collaboratively with the more definitive and capable ICM 12 to enable the collection of physiology by the ICM 12 before, during, and after potentially medically-significant events.
- the wearable physiology monitor, activity sensor 104 , or mobile device 102 must be capable of sensing cardiac activity, particularly heart rate or rhythm, or other types of physiology or measures, either directly or upon review of relayed data.
- the wearable physiology monitor or activity sensor 104 serves as a relay device to trigger a medical alert upon detecting potentially medically-significant events in the data provided by the paired activity monitor, such as cardiac rhythm disorders, including tachyarrhythmias and bradyarrhythmias.
- the wearable physiology monitor or activity sensor 104 has sufficient onboard computational resources and also is equipped with a wireless communications services transceiver, the wearable physiology monitor or activity sensor 104 effectively becomes the mobile device and executes an application (not shown) that will trigger the medical alert directly. Still other configurations of the detection app are possible.
- the monitoring data recorded by the ICM 12 can be uploaded directly into the patient's EMRs 97 , either by using a mobile device 102 as a conduit for communications with the secure database 96 via the server 94 , or directly to the server 94 , if the ICM 12 is appropriately equipped with a wireless transceiver or similar external data communications interface.
- the data recorded by the ICM 12 would directly feed into the patient's EMRs 97 , thereby allowing the data to be made certifiable for immediate use by a physician or authorized healthcare provider.
- the server 94 can evaluate the recorded data, as fed into the patient's EMRs 97 , to refer the patient 10 for medical care to a general practice physician or medical specialist, for instance, a cardiac electrophysiologist referral from a cardiologist when the recorded data indicates an event of sufficient potential severity to warrant the possible implantation of a pacemaker for heart block or a defibrillator for ventricular tachycardia.
- a general practice physician or medical specialist for instance, a cardiac electrophysiologist referral from a cardiologist when the recorded data indicates an event of sufficient potential severity to warrant the possible implantation of a pacemaker for heart block or a defibrillator for ventricular tachycardia.
- Other uses of the data recorded by the ICM 12 are possible. For instance, a patient 10 who has previously suffered heart failure is particularly susceptible to ventricular tachycardia following a period of exercise or strenuous physical activity.
- a wearable sensor 104 or device 102 that includes a heart rate monitor would be able to timely detect an irregularity in heart rhythm.
- the application executed by the sensor 104 or device 102 allows those devices to take action by triggering the dispatch of a ICM 12 to the patient 10 , even though the data recorded by the sensor 104 or device 102 is itself generally medically-insufficient for purposes of diagnosis and care.
- the sensor 104 or device 102 takes on an active role in initiating the provisioning of medical care to the patient 10 and starts a cascade of appropriate medical interventions under the tutelage of and followed by physicians and trained healthcare professionals.
- the ICM 12 could upload an event detection application to the sensor 104 or device 102 to enable those devices to detect those types of potentially medically-significant events.
- the event detection application could be downloaded to the sensor 104 or device 102 from an online application store or similar online application repository.
- the ICM 12 could use the sensor 104 or device 102 to generate an appropriate alert, including contacting the patient's physician or healthcare services, via wireless (or wired) communications, upon detecting a potentially medically-significant event or in response to a patient prompting.
- the mobile device 102 could also serve as a conduit for providing the data collected by the wearable physiology monitor or activity sensor 104 to a server 122 , or, similarly, the wearable physiology monitor or activity sensor 104 could itself directly provide the collected data to the server 122 .
- the server 122 could then merge the collected data into the wearer's EMRs 134 in the secure database 124 , if appropriate (and permissible), or the server 122 could perform an analysis of the collected data, perhaps based by comparison to a population of like wearers of the wearable physiology monitor or activity sensor 104 . Still other server 122 functions on the collected data are possible.
- the ICM 12 can be interrogated using a conventional inductive programmer 100 , which could be interfaced to the application program 98 executing on a physician's device, or in a standalone fashion. Inductive interfacing may be necessary where the transceiver 85 has suffered an error condition or is otherwise unable to communicate externally.
- FIG. 10 is a flow diagram showing an ICM-implemented method 110 for monitoring ECG data.
- the microcontroller 61 executes a power up sequence (step 111 ).
- the voltage of the battery is checked, the state of the flash memory 62 is confirmed, both in terms of operability check and available capacity, and microcontroller operation is diagnostically confirmed.
- an iterative processing loop (steps 112 - 121 ) is continually executed by the microcontroller 61 .
- the ECG frontend 63 (shown in FIG. 11 ) continually senses the dermal ECG electrical signals (step 113 , FIG. 10 ) via the ECG electrodes 16 and 17 and is optimized to maintain the integrity of the P-wave.
- a sample of the ECG signal is read (step 114 ) by the microcontroller 61 by sampling the analog ECG signal that is output by the ECG front end circuit 63 .
- Each sampled ECG signal, in quantized and digitized form, is processed by signal processing modules as specified in firmware (step 115 ), as described infra, and temporarily staged in a buffer (step 116 ), pending compression preparatory to storage in the flash memory 62 (step 117 ).
- the compressed ECG digitized sample is again buffered (step 118 ), then written to the flash memory 62 (step 119 ) using the communications bus.
- an alert that includes the compressed ECG digitized sample can also be wirelessly transmitted upon the triggering of a preset condition (step 120 ), such as an abnormally low heart rate in excess of 170 beats per minute (bpm), an abnormally low heart rate falling below 30 bpm, or AF detected by onboard analysis of RR interval variability by the microcontroller 61 . Processing continues for an indefinite duration (step 121 ). Still other operations and steps are possible.
- the microcontroller 61 operates under modular micro program control that includes processing of raw analog ECG signals.
- FIG. 11 is a functional block diagram showing the signal processing functionality 130 of the microcontroller 61 .
- the microcontroller 61 operates under modular micro program control as specified in firmware 132 .
- the firmware modules 132 include high and low pass filtering 133 , and compression 134 . Other modules are possible.
- the microcontroller 61 has a built-in ADC, although ADC functionality could also be provided in the firmware 132 .
- the ECG front end circuit 63 first outputs an analog ECG signal, which the ADC 131 acquires, samples and converts into an uncompressed digital representation.
- the microcontroller 61 includes one or more firmware modules 133 that perform filtering. In one embodiment, three low pass filters and two high pass filters are used. Following filtering, the digital representation of the cardiac activation wave front amplitudes are compressed by a compression module 134 before being written out to storage 135 .
- the download station 92 (shown in FIG. 9 ) executes a data link program (“DL”) 93 or similar program that wirelessly interfaces with the ILR 12 to retrieve the stored ECG monitoring data and perform other functions.
- FIG. 12 is a functional block diagram showing the operations 140 performed by the download station 141 .
- the download station 141 could be a server, personal computer (as shown), tablet or handheld computer, smart mobile device, or purpose-built programmer designed specific to the task of wirelessly interfacing with a ICM 12 . Still other forms of download station are possible, including download stations connected through indirect wireless interfacing using, for instance, a smart phone connected to the ICM 12 through Bluetooth or Wi-Fi, or over an inductive coupling.
- the download station 141 is responsible for offloading stored ECG monitoring data from a ICM 12 .
- the download station 141 operates under programmable control as specified in software.
- the stored ECG monitoring data remotely retrieved from storage 142 on a ICM 12 is first decompressed by a decompression module 143 , which converts the stored ECG monitoring data back into an uncompressed digital representation more suited to signal processing than a compressed signal.
- the retrieved ECG monitoring data may be stored into local storage (not shown) for archival purposes, either in original compressed form, or as uncompressed.
- the download station 141 can include an array of filtering modules.
- a set of phase distortion filtering tools 144 may be provided, where corresponding software filters can be provided for each filter implemented in the firmware executed by the microcontroller 61 .
- the digital signals are run through the software filters in a reverse direction to remove phase distortion.
- a 45 Hertz high pass filter in firmware may have a matching reverse 45 Hertz high pass filter in software.
- Most of the phase distortion is corrected, that is, canceled to eliminate noise at the set frequency, but data at other frequencies in the waveform remain unaltered.
- bidirectional impulse infinite response (IIR) high pass filters and reverse direction (symmetric) IIR low pass filters can be provided.
- An automatic gain control (AGC) module 145 can also be provided to adjust the digital signals to a usable level based on peak or average signal level or other metric.
- AGC is particularly critical to single-lead ECG monitors, where physical factors, such as the tilt of the heart, can affect the electrical field generated.
- the leads are oriented in vertical, horizontal and diagonal directions. As a result, the horizontal and diagonal leads may be higher amplitude and ECG interpretation will be based on one or both of the higher amplitude leads.
- the ICM 12 has only a single lead that is oriented in the vertical direction, so variations in amplitude will be wider than available with multi-lead monitors, which have alternate leads to fall back upon.
- AGC may be necessary to maintain compatibility with existing ECG interpretation software, which is typically calibrated for multi-lead ECG monitors for viewing signals over a narrow range of amplitudes.
- ECG interpretation software typically calibrated for multi-lead ECG monitors for viewing signals over a narrow range of amplitudes.
- the gain of signals recorded by the ICM 12 of the electrocardiography monitor 12 can be attenuated up (or down) to work with FDA-approved commercially available ECG interpretation.
- AGC can be implemented in a fixed fashion that is uniformly applied to all signals in an ECG recording, adjusted as appropriate on a recording-by-recording basis. Typically, a fixed AGC value is calculated based on how an ECG recording is received to preserve the amplitude relationship between the signals. Alternatively, AGC can be varied dynamically throughout an ECG recording, where signals in different segments of an ECG recording are amplified up (or down) by differing amounts of gain.
- the ICM 12 will record a high resolution, low frequency signal for the P-wave segment similar to the ICM's dermal cousin, such as provided with the dermal ambulatory monitors cited supra. However, for some patients, the result may still be a visually small signal. Although high resolution is present, the unaided eye will normally be unable to discern the P-wave segment. Therefore, gaining the signal is critical to visually depicting P-wave detail. This technique works most efficaciously with a raw signal with low noise and high resolution, as typically generated by the ICM 12 . Automatic gain control applied to a high noise signal will only exacerbate noise content and be self-defeating.
- the download station can include filtering modules specifically intended to enhance P-wave content.
- a P-wave based boost filter 146 which is a form of a pre-emphasis filter, can be applied to the signal to restore missing frequency content or to correct phase distortion. Still other filters and types of signal processing are possible.
- the ICM 12 can simply be inserted with a small surgical incision that is the width of the widest part of the ICM, typically the transverse cross section of the thickest aspect of the housing 15 . Blunt dissection thereafter under local anesthesia can be used to create the subcutaneous space to receive the ICM 12 , which would generally be inserted into the implantation site, proximal (housing) end first, followed by the distal (electrode assembly) end.
- the ICM 12 can be implanted in the patient's chest using, for instance, a minimally invasive subcutaneous implantation instrument, such as described in U.S. Pat. No. 6,436,068, issued Aug. 20, 2002 to Bardy, the disclosure of which is incorporated by reference.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Surgery (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Physiology (AREA)
- Computer Networks & Wireless Communication (AREA)
- Pulmonology (AREA)
- Microelectronics & Electronic Packaging (AREA)
- Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
Abstract
Description
- This application relates in general to electrocardiographic monitoring and, in particular, to a subcutaneous P-wave-centric insertable cardiac monitor (ICM) for long term electrocardiographic monitoring with special emphasis on reliably visualizing the P-wave.
- The electrocardiogram (ECG) was invented by a Dutch physiologist, Willem Einthoven, in 1903. Physicians have since used ECGs to diagnose heart problems and other medical concerns. The medical and engineering principles underlying Einthoven's work are still applicable today, and although ECG machines have evolved to a broad array of different systems, over the past century, the fundamental role of an ECG machine remains the same: to record from the skin surface transmembrane ionic currents that are generated within the heart during cardiac activation and recovery.
- Cardiac depolarization, which is the spread of electrical current throughout the heart, originates in the sinoatrial (SA) node in the right atrium and spreads leftward towards the left atrium and inferiorly towards the atrioventricular (AV) node. Thereafter a delay, occasioned by the AV node, allows atrial blood to enter the ventricles, prior to the continuation of the depolarization current proceeding down the Bundle of His and into the right and left bundle branches, then advancing to the Purkinje fibers, and finally spreading to activate the right and left ventricular muscle fibers themselves that lead to the heart muscle squeezing the blood supply forward.
- During each cardiac cycle, the transmembrane ionic currents create an electrical field in and around the heart that can be detected by ECG electrodes either placed on the skin or implanted under the skin of the thorax to record far field electrical signals from the heart. These far field electrical signals are the captured ECG signals that can be visually depicted in an ECG trace as the PQRSTU waveforms, each letter of which represents a specific electrical activity in the heart well known to cardiologists. Within each cardiac cycle, these waveforms indicate key aspects of cardiac electrical activity. The critical P-wave component of each heartbeat represents atrial electrical activity, the electrical signal that is essential if one is to understand heart rhythm disorders. The QRS components represent ventricular electrical activity, equally critical to understanding heart rhythm disorders. The TU components represent ventricular cell voltages that are the result of resetting cellular currents in preparation for the next cardiac cycle. The TU components are generally of limited value for the purposes of understanding heart rhythm disorders and are rarely addressed in the analysis of heart rhythm disorders per se. (Note that the signals involved in the resetting of the atria are so minuscule as to not be visible in an ECG trace or, even in a standard intra-cardiac recording.)
- Practically, the QRS components of the ventricle electrical activity are often termed the “R-wave,” in brief, as a shorthand way of identifying ventricular electrical activity in its entirety. (Henceforth, the shorthand version of “R-wave” will be used to indicate ventricular activity and “P-wave” will be used to indicate atrial activity.) These “waves” represent the two critical components of arrhythmia monitoring and diagnosis performed every day hundreds of thousands of times across the United States. Without a knowledge of the relationship of these two basic symbols, heart rhythm disorders cannot be reliably diagnosed. Visualizing both the P-wave and the R-wave allow for the specific identification of a variety of atrial tachyarrhythmias (also known as supraventricular tachyarrhythmias, or SVTs), ventricular tachyarrhythmias (VTs), and bradycardias related to sinus node and atrioventricular (AV) node dysfunction. These categories are well understood by cardiologists but only accurately diagnosable if the P-wave and the R-wave are visualized and their relationship and behavior are clear. Visualization of the R-wave is usually readily achievable, as the R-wave is a high voltage, high frequency signal easily recorded from the skin's surface. However, as the ECG bipole spacing and electrode surface area decreases, even the R-wave can be a challenge to visualize. To make matters of rhythm identification more complicated, surface P-waves can be much more difficult to visualize from the surface because of their much lower voltage and signal frequency content. P-wave visualization becomes exacerbated further when the recording bipole inter-electrode spacing decreases.
- Subcutaneous ECG monitors, because of their small size, have greater problems of demonstrating a clear and dependable P-wave. The issues related to a tiny atrial voltage are exacerbated by the small size of insertable cardiac monitors (ICMs), the signal processing limits imposed upon them by virtue of their reduced electrode size, and restricted inter-electrode spacing. Conventional subcutaneous ICMs, as well as most conventional surface ECG monitors, are notorious for poor visualization of the P-wave, which remains the primary reason that heart rhythm disorders cannot precisely be identified today from ICMs. Furthermore, even when physiologically present, the P-wave may not actually appear on an ECG because the P-wave's visibility is strongly dependent upon the signal capturing ability of the ECG recording device's sensing circuitry. This situation is further influenced by several factors, including electrode configuration, electrode surface areas and shapes, inter-electrode spacing; where the electrodes are placed on or within the body relative to the heart's atria. Further, the presence or absence of ambient noise and the means to limit the ambient noise is a key aspect of whether the low amplitude atrial signal can be seen.
- Conventional ICMs are generally capable of monitoring a patient's heart rhythm for up to three years and are often used after diagnostic measures when dermal ECG monitors fail to identify a suspected arrhythmia. Consequently, when a physician is strongly suspicious of a serious cardiac rhythm disorder that may have caused loss of consciousness or stroke, for example, the physician will often proceed to the insertion of an ICM under the skin of the thorax. Although traditionally, the quality of the signal is limited with ICMs with respect to identifying the P-wave, the duration of monitoring is hoped to compensate for poor P-wave recording. This situation has led to a dependence on scrutiny of R-wave behavior, such as RR interval (R-wave-to-R-wave interval) behavior, often used as a surrogate for diagnosing atrial fibrillation, a potential cause of stroke. To a limited extent, this approach has some degree of value. Nevertheless, better recording of the P-wave would result in a significant diagnostic improvement, not only in the case of atrial fibrillation, but in a host of other rhythm disorders that can result in syncope or loss of consciousness, like VT or heart block.
- The P-wave is the most difficult ECG signal to capture by virtue of originating in the low tissue mass atria and having both low voltage amplitude and relatively low frequency content. Notwithstanding these physiological constraints, ICMs are popular, albeit limited in their diagnostic yield. The few ICMs that are commercially available today, including the Reveal LINQ ICM, manufactured by Medtronic, Inc., Minneapolis, Minn., the BioMonitor 2 (AF and S versions), manufactured by Biotronik SE & Co. KG, Berlin, Germany, and the Abbott Confirm Rx ICM, manufactured by Abbott Laboratories, Chicago, Ill., all are uniformly limited in their abilities to clearly and consistently sense, record, and deliver the P-wave.
- Typically, the current realm of ICM devices use a loop recorder where cumulative ECG data lasting for around an hour is continually overwritten unless an episode of pre-programmed interest occurs or a patient marker is manually triggered. The limited temporal window afforded by the recordation loop is yet another restriction on the evaluation of the P-wave, and related cardiac morphologies, and further compromises diagnostic opportunities.
- For instance, Medtronic's Reveal LINQ ICM delivers long-term subcutaneous ECG monitoring for up to three years, depending on programming. The monitor is able to store up to 59 minutes of ECG data, include up to 30 minutes of patient-activated episodes, 27 minutes of automatically detected episodes, and two minutes of the longest atrial fibrillation (AF) episode stored since the last interrogation of the device. The focus of the device is more directed to recording duration and programming options for recording time and patient interactions rather than signal fidelity. The Reveal LINQ ICM is intended for general purpose ECG monitoring and lacks an engineering focus on P-wave visualization. Moreover, the device's recording circuitry is intended to secure the ventricular signal by capturing the R-wave, and is designed to accommodate placement over a broad range of subcutaneous implantation sites, which is usually sufficient if one is focused on the R-wave given its amplitude and frequency content, but of limited value in capturing the low-amplitude, low-frequency content P-wave. Finally, electrode spacing, surface areas, and shapes are dictated (and limited) by the physical size of the monitor's housing which is quite small, an aesthetic choice, but unrealistic with respect to capturing the P-wave.
- Similar in design is the titanium housing of Biotronik's BioMonitor 2 but with a flexible silicone antenna to mount a distal electrode lead, albeit of a standardized length. This standardized length mollifies, in one parameter only, the concerns of limited inter-electrode spacing and its curbing effect on securing the P-wave. None of the other factors related to P-wave signal revelation are addressed. Therefore the quality of sensed P-waves reflects a compromise caused by closely-spaced poles that fail to consistently preserve P-wave fidelity, with the reality of the physics imposed problems of signal-to-noise ratio limitations remaining mostly unaddressed.
- Therefore, a need remains for a continuously recording long-term ICM particularly attuned to capturing low amplitude cardiac action potential propagation from the atria, that is, the P-wave, for accurate arrhythmia event capture and subsequent diagnosis.
- Long-term electrocardiographic and physiological monitoring over a period lasting up to several years in duration can be provided through a continuously-recording subcutaneous insertable cardiac monitor (ICM). The sensing circuitry and the physical layout of the electrodes are specifically optimized to capture electrical signals from the propagation of low amplitude, relatively low frequency content cardiac action potentials, particularly the P-waves that are generated during atrial activation. In general, the ICM is intended to be implanted centrally and positioned axially and slightly to either the left or right of the sternal midline in the parasternal region of the chest.
- One embodiment provides a P-wave centric subcutaneous insertable cardiac monitor for use in performing long term electrocardiographic (ECG) monitoring. An implantable housing made of a biocompatible material that is suitable for implantation within a living body is provided. At least one pair of ECG sensing electrodes is provided on a ventral (or dorsal) surface and on opposite ends of the implantable housing operatively placed to facilitate sensing in closest proximity to the low amplitude, low frequency content cardiac action potentials that are generated during atrial activation. Electronic circuitry is provided within the housing assembly including a low power microcontroller operable to execute under modular micro program control as specified in firmware, an ECG front end circuit interfaced to the microcontroller and configured to capture the cardiac action potentials sensed by the pair of ECG sensing electrodes which are output as ECG signals, and non-volatile memory electrically interfaced with the microcontroller and operable to continuously store samples of the ECG signals.
- Still other embodiments will become readily apparent to those skilled in the art from the following detailed description, wherein are described embodiments by way of illustrating the best mode contemplated. As will be realized, other and different embodiments are possible and the embodiments' several details are capable of modifications in various obvious respects, all without departing from their spirit and the scope. Accordingly, the drawings and detailed description are to be regarded as illustrative in nature and not as restrictive.
-
FIG. 1 is a diagram showing, by way of example, a subcutaneous P-wave centric insertable cardiac monitor (ICM) for long term electrocardiographic monitoring in accordance with one embodiment. -
FIGS. 2 and 3 are respectively top and bottom perspective views showing the ICM ofFIG. 1 . -
FIG. 4 is a bottom perspective view showing the ICM ofFIG. 1 in accordance with a further embodiment. -
FIGS. 5 and 6 are respectively top and bottom perspective views showing an ICM in accordance with a still further embodiment. -
FIG. 7 is a plan view showing further electrode configurations. -
FIG. 8 is a functional block diagram showing the P-wave focused component architecture of the circuitry of the ICM ofFIG. 1 . -
FIG. 9 is a functional block diagram showing a system for wirelessly interfacing with an ICM in accordance with one embodiment. -
FIG. 10 is a flow diagram showing an ICM-implemented method for monitoring ECG data. -
FIG. 11 is a functional block diagram showing the signal processing functionality of the microcontroller. -
FIG. 12 is a functional block diagram showing the operations performed by the download station. - Long-term electrocardiographic and physiological monitoring over a period lasting up to several years in duration can be provided through a continuously-recording subcutaneous insertable cardiac monitor (ICM).
FIG. 1 is a diagram showing, by way of example, a subcutaneous P-wavecentric ICM 12 for long term electrocardiographic monitoring in accordance with one embodiment. TheICM 12 is implanted in theparasternal region 11 of apatient 10. The sensing circuitry and components, compression algorithms, and the physical layout of the electrodes are specifically optimized to capture electrical signals from the propagation of low amplitude, relatively low frequency content cardiac action potentials, particularly the P-waves generated during atrial activation. The position and placement of theICM 12 coupled to engineering considerations that optimize the ICM's sensing circuitry, discussed infra, aid in demonstrating the P-wave clearly. - Implantation of a P-wave
centric ICM 12 in the proper subcutaneous site facilitates the recording of high quality ECG data with a good delineation of the P-wave. In general, theICM 12 is intended to be implanted anteriorly and be positioned axially and slightly to either the right or left of the sternal midline in theparasternal region 11 of the chest, or if sufficient subcutaneous fat exists, directly over the sternum. Optimally, theICM 12 is implanted in a location left parasternally to bridge the left atrial appendage. However, either location to the right or left of the sternal midline is acceptable; placement of the device, if possible, should bridge the vertical height of the heart, which lies underneath thesternum 7, thereby placing theICM 12 in close proximity to the anterior right atrium and the left atrial appendage that lie immediately beneath. - The
ICM 12 is shaped to fit comfortably within the body under the skin and to conform to the contours of the patient'sparasternal region 11 when implanted immediately to either side of thesternum 7, but could be implanted in other locations of the body. In most adults, theproximal end 13 of theICM 12 is generally positioned below themanubrium 8 but, depending upon patient's vertical build, theICM 12 may actually straddle the region over themanubrium 8. Thedistal end 14 of theICM 12 generally extends towards thexiphoid process 9 and lower sternum but, depending upon the patient's build, may actually straddle the region over or under thexiphoid process 9, lower sternum and upper abdomen. - Although internal tissues, body structures, and tissue boundaries can adversely affect the current strength and signal fidelity of all body surface potentials, subsurface low amplitude cardiac action potentials, particularly P-wave signals with a normative amplitude of less than 0.25 millivolts (mV) and a normative duration of less than 120 milliseconds (ms), are most apt to be negatively impacted by these factors. The atria, which generate the P wave, are mostly located posteriorly within the thoracic cavity (with the exception of the anterior right atrium, right atrial appendage and left atrial appendage). The majority of the left atrium constitutes the portion of the heart furthest away from the surface of the skin on the chest and harbors the atrial tissue most likely to be the source of serious arrhythmias, like atrial fibrillation. Conversely, the ventricles, which generate larger amplitude signals, are located anteriorly as in the case of the anterior right ventricle and most of the anterior left ventricle situated relatively close to the skin surface of the central and left anterior chest. These factors, together with larger size and more powerful impulse generation from the ventricles, contribute to the relatively larger amplitudes of ventricular waveforms.
- Nevertheless, as explained supra, both the P-wave and the R-wave are required for the physician to make a proper rhythm diagnosis from the dozens of arrhythmias that can occur. Yet, the quality of P-waves is more susceptible to weakening from distance and the intervening tissues and structures and from signal attenuation and signal processing than the high voltage waveforms associated with ventricular activation. The added value of avoiding further signal attenuation resulting from dermal impedance makes a subcutaneous P-wave centric ICM even more likely to match, or even outperform dermal ambulatory monitors designed to analogous engineering considerations and using similar sensing circuitry and components, compression algorithms, and physical layout of electrodes, such as described in U.S. Pat. No. 9,545,204, issued Jan. 17, 2017 to Bishay et al.; U.S. Pat. No. 9,730,593, issued Aug. 15, 2017 to Felix et al.; U.S. Pat. No. 9,700,227, issued Jul. 11, 2017 to Bishay et al.; U.S. Pat. No. 9,717,433, issued Aug. 1, 2017 to Felix et al.; and U.S. Pat. No. 9,615,763, issued Apr. 11, 2017 to Felix et al., the disclosures of which are incorporated by reference.
- The
ICM 12 can be implanted in the patient's chest using, for instance, a minimally invasive subcutaneous implantation instrument or other suitable surgical implement. TheICM 12 is positioned slightly to the right or left of midline, covering the center third of the chest, roughly between the second and sixth ribs, approximately spanning between the level of themanubrium 8 and the level of thexiphoid process 9 on the inferior border of thesternum 7, depending upon the vertical build of thepatient 10. - During monitoring, the amplitude and strength of action potentials sensed by an ECG devices, including dermal ECG monitors and ICMs, can be affected to varying degrees by cardiac, cellular, extracellular, vector of current flow, and physical factors, like obesity, dermatitis, lung disease, large breasts, and high impedance skin, as can occur in dark-skinned individuals. Performing ECG sensing subcutaneously in the
parasternal region 11 significantly improves the ability of theICM 12 to counter some of the effects of these factors, particularly high skin impedance and impedance from subcutaneous fat. Thus, theICM 12 exhibits superior performance when compared to conventional dermal ECG monitors to existing implantable loop recorders, ICMs, and other forms of implantable monitoring devices by virtue of its engineering and proven P-wave documentation above the skin, as discussed in W. M. Smith et al., “Comparison of diagnostic value using a small, single channel, P-wave centric sternal ECG monitoring patch with a standard 3-lead Holter system over 24 hours,” Am. Heart J., March 2017; 185:67-73, the disclosure of which is incorporated by reference. - Moreover, the sternal midline implantation location in the
parasternal region 11 allows the ICM's electrodes to record an ECG of optimal signal quality from a location immediately above the strongest signal-generating aspects of the atrial. Signal quality is improved further in part because cardiac action potential propagation travels simultaneously along a north-to-south and right-to-left vector, beginning high in the right atrium and ultimately ending in the posterior and lateral region of the left ventricle. Cardiac depolarization originates high in the right atrium in the SA node before concurrently spreading leftward towards the left atrium and inferiorly towards the atrioventricular (AV) node. On theproximal end 13, the ECG electrodes of theICM 12 are subcutaneously positioned with the upper or superior pole (ECG electrode) slightly to the right or left of the sternal midline in the region of themanubrium 8 and, on thedistal end 14, the lower or inferior pole (ECG electrode) is similarly situated slightly to the right or left of the sternal midline in the region of thexiphoid process 9 andlower sternum 7. The ECG electrodes of theICM 12 are placed primarily in a north-to-south orientation along thesternum 7 that corresponds to the north-to-south waveform vector exhibited during atrial activation. This orientation corresponds to the aVF lead used in a conventional 12-lead ECG that is used to sense positive or upright P-waves. In addition, the electrode spacing and the electrodes' shapes and surface areas mimic the electrodes used in the ICM's dermal cousin, designed as part of the optimal P-wave sensing electrode configuration, such as provided with the dermal ambulatory monitors cited supra. - Despite the challenges faced in capturing low amplitude cardiac action potentials, the
ICM 12 is able to operate effectively using only two electrodes that are strategically sized and placed in locations ideally suited to high fidelity P-wave signal acquisition. This approach has been shown to clinically outperform more typical multi-lead monitors because of the improved P-wave clarity, as discussed in W. M. Smith et al., cited supra.FIGS. 2 and 3 are respectively top and bottom perspective views showing theICM 12 ofFIG. 1 . Physically, theICM 12 is constructed with a hermetically sealedimplantable housing 15 with at least one ECG electrode forming a superior pole on theproximal end 13 and at least one ECG electrode forming an inferior pole on thedistal end 14. - When implanted, the
housing 15 is oriented most cephalad. Thehousing 15 is constructed of titanium, stainless steel or other biocompatible material. Thehousing 15 contains the sensing, recordation and interfacing circuitry of theICM 12, plus a long life battery. A wireless antenna is integrated into or within thehousing 15 and can be positioned to wrap around the housing's internal periphery or location suited to signal reception. Other wireless antenna placement or integrations are possible. - Physically, the
ICM 12 has fourECG electrodes ECG electrodes wraparound ECG electrodes ventral ECG electrode 18 is formed on theproximal end 13 and oneventral ECG electrode 19 is formed on thedistal end 14. Onewraparound ECG electrode 16 is formed circumferentially about theproximal end 13 and onewraparound ECG electrode 17 is formed circumferentially about thedistal end 14. Eachwraparound ECG electrode ventral ECG electrode periphery - The four
ECG electrodes ventral ECG electrodes wraparound ECG electrodes ventral ECG electrode wraparound ECG electrode housing 15. In addition, theperiphery wraparound ECG electrode ICM 12 with its correspondingventral ECG electrode ICM 12, for instance,wraparound ECG electrode 16 andventral ECG electrode 18, could be paired; however, the minimal inter-electrode spacing would likely yield a signal of poor fidelity in most situations.) - In a further embodiment, the
housing 15 and contained circuitry can be provided as a standalone ICM core assembly to which a pair of compatible ECG electrodes can be operatively coupled to form a full implantable ICM device. - Other ECG electrode configurations are possible. For instance, additional ECG electrodes can be provided to increase the number of possible electrode configurations, all of which are to ensure better P-wave resolution.
FIG. 4 is a bottom perspective view showing theICM 12 ofFIG. 1 in accordance with a further embodiment. An additional pair ofventral ECG electrodes ventral ECG electrodes ventral ECG electrodes housing 15 and a physician can thus choose to pair the two innerventral ECG electrodes other ECG electrodes - Other housing configurations of the ICM are possible. For instance, the housing of the ICM can be structured to enhance long term comfort and fitment, and to accommodate a larger long life battery or more circuitry or features, including physiologic sensors, to provide additional functionality.
FIGS. 5 and 6 are respectively top and bottom perspective views showing anICM 30 in accordance with a still further embodiment. TheICM 30 has ahousing 31 with atapered extension 32 that is terminated on the distal end with anelectrode 34. On a proximal end, thehousing 31 includes a pair of ECG electrodes electrically insulated by aperiphery 37 that include aventral ECG electrode 33 and awraparound ECG electrode 34. In addition, aventral ECG electrode 36 is oriented on the housing's distal end before the taperedextension 32. Still other housing structures and electrode configurations are possible. - In general, the basic electrode layout is sufficient to sense cardiac action potentials in a wide range of patients. Differences in thoracic tissue density and skeletal structure from patient to patient, though, can affect the ability of the sensing electrodes to efficaciously capture action potential signals, yet the degree to which signal acquisition is affected may not be apparent until after an ICM has been implanted and deployed, when the impacts of the patient's physical constitution and his patterns of mobility and physical movement on ICM monitoring can be fully assessed.
- In further embodiments, the electrodes can be configured post-implant to allow the ICM to better adapt to a particular patient's physiology. For instance, electrode configurations having more than two sensing electrodes are possible.
FIG. 7 is a plan view showing further electrode configurations. Referring first toFIG. 7(a) , a singledisc ECG electrode 40 could be bifurcated to form a pair of half-circle ECG electrodes FIG. 7(b) , a singledisc ECG electrode 45 could be divided into three sections, a pair of crescent-shapedECG electrodes semicircular ECG electrode 48 that could similarly be programmatically selected or combined. Still other ECG electrode configurations are possible. - ECG monitoring and other functions performed by the
ICM 12 are provided through a micro controlled architecture.FIG. 8 is a functional block diagram showing the P-wave focused component architecture of thecircuitry 80 of theICM 12 ofFIG. 1 . Thecircuitry 80 is powered through thelong life battery 21 provided in thehousing 15. Operation of thecircuitry 80 of theICM 12 is managed by amicrocontroller 81, such as the EFM32 Tiny Gecko 32-bit microcontroller, manufactured by Silicon Laboratories Inc., Austin, Tex. Themicrocontroller 81 has flexible energy management modes and includes a direct memory access controller and built-in analog-to-digital and digital-to-analog converters (ADC and DAC, respectively). Themicrocontroller 81 also includes a program memory unit containing internal flash memory (not shown) that is readable, writeable, and externally programmable. - The
microcontroller 81 operates under modular micro program control as specified in firmware stored in the internal flash memory. The functionality and firmware modules relating to signal processing by themicrocontroller 81 are further described infra with reference toFIG. 11 . Themicrocontroller 81 draws power from the battery provided in thehousing 15 and connects to the ECGfront end circuit 83. In a further embodiment, thefront end circuit 83 measures raw dermal electrical signals using a driven reference signal that eliminates common mode noise, as further described infra. - The
circuitry 80 of theICM 12 also includes aflash memory 82 external to themicrocontroller 81, which themicrocontroller 81 uses for continuously storing samples of ECG monitoring signal data and other physiology, such as respiratory rate, blood oxygen saturation level (SpO2), blood pressure, temperature sensor, and physical activity, and device and related information. Theflash memory 82 also draws power from the battery provided in thehousing 15. Data is stored in a serial flash memory circuit, which supports read, erase and program operations over a communications bus. Theflash memory 82 enables themicrocontroller 81 to store digitized ECG data. The communications bus further enables theflash memory 82 to be directly accessed wirelessly through atransceiver 85 coupled to anantenna 17 built into (or provided with) thehousing 15, as further described infra with reference toFIG. 9 . Thetransceiver 85 can be used for wirelessly interfacing over Bluetooth or other types of wireless technologies for exchanging data over a short distance with a paired mobile device, including smartphones and smart watches, that are designed to communicate over a public communications infrastructure, such as a cellular communications network, and, in a further embodiment, other wearable (or implantable) physiology monitors, such as activity trackers worn on the wrist or body. Other types of device pairings are possible, including with a desktop computer or purpose-built bedside monitor. Thetransceiver 85 can be used to offload stored ECG monitoring data and other physiology data and information and for device firmware reprogramming. In a further embodiment, theflash memory 82 can be accessed through an inductive coupling (not shown). - The
microcontroller 81 includes functionality that enables the acquisition of samples of analog ECG signals, which are converted into a digital representation, as further described infra with reference toFIG. 11 . In one mode, themicrocontroller 81 implements a loop recorder feature that will acquire, sample, digitize, signal process, and store digitized ECG data into available storage locations in theflash memory 82 until all memory storage locations are filled, after which existing stored digitized ECG data will either be overwritten through a sliding window protocol, albeit at the cost of potentially losing the stored data that was overwritten, if not previously downloaded, or transmitted wirelessly to an external receiver to unburden the flash memory. In another mode, the stored digitized ECG data can be maintained permanently until downloaded or erased to restore memory capacity. Data download or erasure can also occur before all storage locations are filled, which would free up memory space sooner, albeit at the cost of possibly interrupting monitoring while downloading or erasure is performed. Still other modes of data storage and capacity recovery are possible. - The
circuitry 80 of theICM 12 can include functionality to programmatically select pairings of sensing electrodes when theICM 12 is furnished with three or more electrodes. In a further embodiment, multiple sensing electrodes could be provided on theICM 12 to provide a physician the option of fine-tuning the sensing dipole (or tripole or multipole) in situ by parking active electrodes and designating any remaining electrodes inert. The pairing selection can be made remotely through an inductive coupling or by thetransceiver 85 via, for instance, a paired mobile device, as further described infra. Thus, the sensing electrode configuration, including number of electrodes, electrode-to-electrode spacing, and electrode size, shape, surface area, and placement, can be modified at any time during the implantation of theICM 12. - In a further embodiment, the
circuitry 80 of theICM 12 can include anactigraphy sensor 84 implemented as a 3-axis accelerometer. The accelerometer may be configured to generate interrupt signals to themicrocontroller 81 by independent initial wake up and free fall events, as well as by device position. In addition, the actigraphy provided by the accelerometer can be used during post-monitoring analysis to correct the orientation of theICM 12 if, for instance, theICM 12 has been inadvertently implanted upside down, that is, with the ICM's housing oriented caudally, as well as for other event occurrence analyses. - In a still further embodiment, the
circuitry 80 of theICM 12 can include one or more physiology sensors. For instance, a physiology sensor can be provided as part of thecircuitry 80 of theICM 12, or can be provided on theelectrode assembly 14 with communication with themicrocontroller 81 provided through a circuit trace. The physiology sensor can include an SpO2 sensor, blood pressure sensor, temperature sensor, respiratory rate sensor, glucose sensor, airflow sensor, volumetric pressure sensing, or other types of sensor or telemetric input sources. - In a yet further embodiment, firmware with programming instructions, including machine learning and other forms of artificial intelligence-originated instructions, can be downloaded into the microcontroller's internal flash memory. The firmware can include heuristics to signal patient and physician with alerts over health conditions or arrhythmias of selected medical concern, such as where a heart pattern particular to the patient is identified and the
ICM 12 is thereby reprogrammed to watch for a reoccurrence of that pattern, after which an alert will be generated and sent to the physician (or other caregiver) through thetransceiver 85 via, for instance, a paired mobile device. Similarly, the firmware can include heuristics that can be downloaded to theICM 12 to actively identify or narrow down a pattern (or even the underlying cause) of sporadic cardiac conditions, for instance, atrial tachycardia (AT), atrial fibrillation (AF), atrial flutter (AFL), AV node reciprocating tachycardia, ventricular tachycardia (VT), sinus bradycardia, asystole, complete heart block, and other cardiac arrhythmias, again, after which an alert will be generated and sent to the physician (or other caregiver) through thetransceiver 85. For instance, an alert that includes a compressed ECG digitized sample can also be wirelessly transmitted by theICM 12 upon the triggering of a preset condition, such as an abnormally low heart rate in excess of 170 beats per minute (bpm), an abnormally low heart rate falling below 30 bpm, or AF detected by onboard analysis of RR interval variability by themicrocontroller 61. Finally, a similar methodology of creating firmware programming tailored to the monitoring and medical diagnostic needs of a specific patient (or patient group or general population) can be used for other conditions or symptoms, such as syncope, palpitations, dizziness and giddiness, unspecified convulsions, abnormal ECG, transient cerebral ischemic attacks and related syndromes, cerebral infarction, occlusion and stenosis of pre-cerebral and cerebral arteries not resulting in cerebral infarction personal history of transient ischemic attack, and cerebral infarction without residual deficits, to trigger an alert and involve the physician or initiate automated analysis and follow up back at the patient's clinic. Finally, in a still further embodiment, thecircuitry 80 of theICM 12 can accommodate patient-interfaceable components, including an external tactile feedback device (not shown) that wirelessly interfaces to theICM 12 through thetransceiver 85. A patient 10 can press the external tactile feedback device to mark events, such as a syncope episode, or to perform other functions. Thecircuitry 80 can also accommodate triggering an external buzzer 67, such as a speaker, magnetic resonator or piezoelectric buzzer, implemented as part of the external tactile feedback device or as a separate wirelessly-interfaceable component. The buzzer 67 can be used by themicrocontroller 81 to indirectly output feedback to apatient 10, such as a low battery or other error condition or warning. Still other components, provided as either part of thecircuitry 80 of theICM 12 or as external wirelessly-interfaceable devices, are possible. - In a further embodiment, the ECG
front end circuit 83 of theICM 12 measures raw dermal electrical signals using a driven reference signal, such as described in U.S. Pat. Nos. 9,700,227, 9,717,433, and 9,615,763, cited supra. The driven reference signal effectively reduces common mode noise, power supply noise and system noise, which is critical to preserving the characteristics of low amplitude cardiac action potentials, especially the P wave signals originating from the atria. - The ECG
front end circuit 83 is organized into a passive input filter stage, a unity gain voltage follower stage, a passive high pass filtering stage, a voltage amplification and active filtering stage, and an anti-aliasing passive filter stage, plus a reference generator. The passive input filter stage passively shifts the frequency response poles downward to counter the high electrode impedance from the patient on the signal lead and reference lead, which reduces high frequency noise. The unity gain voltage follower stage allows the circuit to accommodate a very high input impedance, so as not to disrupt the subcutaneous potentials or the filtering effect of the previous stage. The passive high pass filtering stage includes a high pass filter that removes baseline wander and any offset generated from the previous stage. As necessary, the voltage amplification and active filtering stage amplifies or de-amplifies (or allows to pass-through) the voltage of the input signal, while applying a low pass filter. The anti-aliasing passive filter stage 75 provides an anti-aliasing low pass filter. The reference generator drives a driven reference signal containing power supply noise and system noise to the reference lead and is connected directly to the patient, thereby avoiding the thermal noise of the protection resistor that is included as part of the protection circuit 72. - When operated standalone, the recording circuitry of the
ICM 12 senses and records the patient's ECG data into an onboard memory. TheICM 12 can interoperate with other devices wirelessly through thetransceiver 85.FIG. 9 is a functional block diagram showing asystem 90 for wirelessly interfacing with anICM 12 in accordance with one embodiment. TheICM 12 is designed for long-term electrocardiographic and physiological monitoring lasting up to several years in duration. During that time, stored data ECG monitoring data and other physiology and information will need to be offloaded and the ICM's firmware may need to be reprogrammed, and thetransceiver 85 enables theICM 12 to communicate with external devices to facilitate these functions. - In one embodiment, the
ICM 12 can be wirelessly connected to adownload station 92 executing data link software (“DL”) 93 that permits the secure remote retrieval of stored ECG monitoring data, execution of diagnostics on or programming of theICM 12, or performance of other functions. TheICM 12 connects to thedownload station 92 over awireless network 91 via thetransceiver 85. In turn, thedownload station 92 executes thedata link software 93 or similar program that wirelessly interacts with theICM 12 to retrieve the stored ECG monitoring data or perform other function. Thedownload station 92 could be a server, personal computer, tablet or handheld computer, smart mobile device, or purpose-built programmer designed specific to the task of interfacing with aICM 12. Still other forms ofdownload station 92 are possible. - Upon retrieving stored ECG monitoring data from a
ICM 12, middleware (not shown) executing on thedownload station 92 first operates on the retrieved data to adjust the ECG capture quality, as necessary, and to convert the retrieved data into a format suitable for use by third party post-monitoring analysis software, as further described infra with reference toFIG. 12 . The formatted data can then be retrieved from thedownload station 92. The middleware could alternatively be executed by a separate device other than thedownload station 92. - A client-server model could be used to employ a
server 94 to remotely interface with thedownload station 92 over thenetwork 91 and retrieve the formatted data or other information. Theserver 94 executes a patient management program 95 (“Mgt”) or similar application that stores the retrieved formatted data, recorded physiology, and other information in asecure database 96 cataloged in that patient's electronic medical records (EMRs) 97, along with tracking and correlating patient symptoms. In addition, thepatient management program 95 could manage a subscription service that authorizes aICM 12 to operate for a set period of time or under pre-defined operational parameters. - The
patient management program 95, or other trusted application, also maintains and safeguards thesecure database 96 to limit access topatient EMRs 97 to only authorized parties for appropriate medical or other uses, such as mandated by state or federal law, such as under the Health Insurance Portability and Accountability Act (HIPAA) or per the European Union's Data Protection Directive. For example, a physician may seek to review and evaluate his patient's ECG monitoring data, as securely stored in thesecure database 96. - Physician and other authorized healthcare personnel are able to securely access the retrieved formatted data and other information stored in the
EMRs 97 in thesecure database 96 by executing an application program (“MD”) 98, such as a post-monitoring ECG analysis program, on apersonal computer 99 or other connectable computing device, and, through theapplication program 98, coordinate access to his patient'sEMRs 97 with thepatient management program 95 and perform other functions. Theapplication program 98 can include the capability to actively or interactively diagnose or narrow down the underlying cause of sporadic cardiac conditions, for instance, atrial tachycardia (AT), AF, atrial flutter, AV node reciprocating tachycardia, ventricular tachycardia (VT), sinus bradycardia, asystole, complete heart block, and other cardiac arrhythmias. Other diagnoses are possible. - In a further embodiment, RR interval data can be extracted from the retrieved formatted data and be presented to physicians in a format that includes views of relevant near field and far field ECG data, which together provide contextual information that improves diagnostic accuracy, such as described in U.S. Pat. No. 9,408,551, issued Aug. 9, 2016 to Bardy et al., the disclosure of which is incorporated by reference. Both near field and far field ECG data views are temporally keyed to an extended duration RR interval data view. The durations of the classical “pinpoint” view, the pre- and post-event “intermediate” view, and the RR interval plot are flexible and adjustable. Thus, the pinpoint “snapshot” and intermediate views of ECG data with the extended term RR interval data allow a physician to comparatively view heart rate context and patterns of behavior prior to and after a clinically meaningful arrhythmia, patient concern or other indicia, thereby enhancing diagnostic specificity of cardiac rhythm disorders and providing physiological context to improve diagnostic ability.
- As a result, with the assistance of the
server 94, a complete end-to-end closed loop of patient care can be provided, with theICM 12 providing long-term ECG and physiology monitoring and data reporting, thepatient management program 95 managing ECG and physiology data retrieval and patient symptom tracking and correlation, theapplication program 98 empowering physicians with the ability to effectively identify the underlying cause of sporadic cardiac conditions, particularly cardiac rhythm disorders, and theICM 12 again facilitating patient following upon diagnosis and throughout treatment. - In a further embodiment, the
ICM 12 can interoperate wirelessly with other physiology monitors andactivity sensors 104, whether implanted or dermal, such as activity trackers worn on the wrist or body, and withmobile devices 102, including smartphones and smart watches, that are designed to communicate over a public communications infrastructure, such as a cellular communications network. Wearable physiology monitors andactivity sensors 104 encompass a wide range of wirelessly interconnectable devices that measure or monitor a patient's physiological data, such as heart rate, temperature, blood pressure, respiratory rate, blood pressure, blood sugar (with appropriate subcutaneous probe), oxygen saturation, minute ventilation, and so on; physical states, such as movement, sleep, footsteps, and the like; and performance, including calories burned or estimated blood glucose level. - The physiology sensors in non-wearable
mobile devices 102, particularly smartphones, are generally not meant for continuous tracking and do not provide medically precise and actionable data sufficient for a physician to prescribe a surgical, catheter or serious drug intervention; such data can be considered screening information that something may be wrong, but not data that provides the highly precise information that may allow for a surgery, such as implantation of a pacemaker for heart block or a defibrillator for ventricular tachycardia, or the application of serious medications, like blood thinners for atrial fibrillation or a cardiac ablation procedure. Such devices, like smartphones, are better suited to pre- and post-exercise monitoring or as devices that can provide a signal that something is wrong, but not in the sufficient detail and FDA approved, legally meaningful validation to allow for medical action. Conversely, medically actionable wearable sensors and devices sometimes provide continuous recording for relatively short time periods, up to 80 days, but do not span years and, further, must be paired with a smartphone or computer to offload and evaluate the recorded data, especially if the data is of urgent concern. - Wearable physiology monitors and
activity sensors 104, also known as “activity monitors,” and to a lesser extent, “fitness” sensor-equippedmobile devices 102, can trace their life-tracking origins to ambulatory devices used within the medical community to sense and record traditional medical physiology that could be useful to a physician in arriving at a patient diagnosis or clinical trajectory, as well as from outside the medical community, from, for instance, sports or lifestyle product companies who seek to educate and assist individuals with self-quantifying interests. Data is typically tracked by the wearable physiology monitors oractivity sensors 104 andmobile device 102 for only the personal use of the wearer. The physiological monitoring is strictly informational, even where a device originated within the medical community, and the data is generally not time-correlated to physician-supervised monitoring. Importantly, medically-significant events, such as cardiac rhythm disorders, including tachyarrhythmias, like ventricular tachycardia or atrial fibrillation, and bradyarrhythmias, like heart block, while potentially detectable with the appropriate diagnostic heuristics, are neither identified nor acted upon by the wearable physiology monitors andactivity sensors 104 and themobile device 102. - Frequently, wearable physiology monitors and
activity sensors 104 are capable of wirelessly interfacing withmobile devices 102, particularly smart mobile devices, including so-called “smartphones” and “smart watches,” as well as with personal computers and tablet or handheld computers, to download monitoring data either in real-time or in batches. The wireless interfacing of such activity monitors is generally achieved using transceivers that provide low-power, short-range wireless communications, such as Bluetooth, although some wearable physiology monitors andactivity sensors 104, like their mobile device cohorts, have transceivers that provide true wireless communications services, including 4G or better mobile telecommunications, over a telecommunications network. Other types of wireless and wired interfacing are possible. - In a further embodiment, where the wearable physiology monitors and
activity sensors 104 are paired with amobile device 102, themobile device 102 executes an application (“App”) 103 that can retrieve the data collected by the wearable physiology monitor andactivity sensor 104 and evaluate the data to generate information of interest to the wearer, such as an estimation of the effectiveness of the wearer's exercise efforts. Where the wearable physiology monitors andactivity sensors 104 has sufficient onboard computational resources, the activity monitor itself executes an app without the need to relay data to amobile device 102. The app can include or be supplemented by downloadable programming instructions, including machine learning and other forms of artificial intelligence-originated instructions. The app can include heuristics to signal patient and physician with alerts over health conditions or arrhythmias of selected medical concern, such as where a heart pattern particular to the patient is identified and themobile device 102, in collaboration with theICM 12, is thereby reprogrammed to watch for a reoccurrence of that pattern, after which an alert will be generated and sent to the physician (or other caregiver). Similarly, the app can include heuristics that can actively identify or narrow down a pattern (or even the underlying cause) of sporadic cardiac conditions, for instance, atrial tachycardia (AT), atrial fibrillation (AF), atrial flutter (AFL), AV node reciprocating tachycardia, ventricular tachycardia (VT), sinus bradycardia, asystole, complete heart block, and other cardiac arrhythmias, again, after which an alert will be generated and sent to the physician (or other caregiver). For instance, an alert that includes a compressed ECG digitized sample can also be wirelessly transmitted by the app upon the triggering of a preset condition, such as an abnormally low heart rate in excess of 170 beats per minute (bpm), an abnormally low heart rate falling below 30 bpm, or AF detected by onboard analysis of RR interval variability by the app. Finally, a similar methodology of creating app programming tailored to the monitoring and medical diagnostic needs of a specific patient (or patient group or general population) can be used for other conditions or symptoms, such as syncope, palpitations, dizziness and giddiness, unspecified convulsions, abnormal ECG, transient cerebral ischemic attacks and related syndromes, cerebral infarction, occlusion and stenosis of pre-cerebral and cerebral arteries not resulting in cerebral infarction personal history of transient ischemic attack, and cerebral infarction without residual deficits, to trigger an alert and involve the physician or initiate automated analysis and follow up back at the patient's clinic. Still other activity monitor and mobile device functions on the collected data are possible. - In a yet further embodiment, a wearable physiology monitor,
activity sensor 104, ormobile device 102 worn or held by thepatient 10, or otherwise be used proximal to the patient's body, can be used to first obtain and then work collaboratively with the more definitive andcapable ICM 12 to enable the collection of physiology by theICM 12 before, during, and after potentially medically-significant events. The wearable physiology monitor,activity sensor 104, ormobile device 102 must be capable of sensing cardiac activity, particularly heart rate or rhythm, or other types of physiology or measures, either directly or upon review of relayed data. Where the wearable physiology monitor oractivity sensor 104 is paired with amobile device 102, themobile device 102 serves as a relay device to trigger a medical alert upon detecting potentially medically-significant events in the data provided by the paired activity monitor, such as cardiac rhythm disorders, including tachyarrhythmias and bradyarrhythmias. Finally, if the wearable physiology monitor oractivity sensor 104 has sufficient onboard computational resources and also is equipped with a wireless communications services transceiver, the wearable physiology monitor oractivity sensor 104 effectively becomes the mobile device and executes an application (not shown) that will trigger the medical alert directly. Still other configurations of the detection app are possible. - In a still further embodiment, the monitoring data recorded by the
ICM 12 can be uploaded directly into the patient'sEMRs 97, either by using amobile device 102 as a conduit for communications with thesecure database 96 via theserver 94, or directly to theserver 94, if theICM 12 is appropriately equipped with a wireless transceiver or similar external data communications interface. Thus, the data recorded by theICM 12 would directly feed into the patient'sEMRs 97, thereby allowing the data to be made certifiable for immediate use by a physician or authorized healthcare provider. No intermediate steps would be necessary when going from subcutaneously sensing cardiac electric signals and collecting the patient's physiology using aICM 12 to presenting that recorded data to a physician or healthcare provider for medical diagnosis and care. The direct feeding of data from theICM 12 to theEMRs 97 clearly establishes the relationship of the data, as recorded by theICM 12, to the patient 10 that the physician is seeing and appropriately identifies any potentially medically-significant event recorded in the data as originating in thepatient 10 and nobody else. Based on the monitoring data, physicians and healthcare providers can rely on the data as certifiable and can directly proceed with determining the appropriate course of treatment for the patient 10, including undertaking further medical interventions as appropriate. - In a yet further embodiment, the
server 94 can evaluate the recorded data, as fed into the patient'sEMRs 97, to refer thepatient 10 for medical care to a general practice physician or medical specialist, for instance, a cardiac electrophysiologist referral from a cardiologist when the recorded data indicates an event of sufficient potential severity to warrant the possible implantation of a pacemaker for heart block or a defibrillator for ventricular tachycardia. Other uses of the data recorded by theICM 12 are possible. For instance, a patient 10 who has previously suffered heart failure is particularly susceptible to ventricular tachycardia following a period of exercise or strenuous physical activity. Awearable sensor 104 ordevice 102 that includes a heart rate monitor would be able to timely detect an irregularity in heart rhythm. The application executed by thesensor 104 ordevice 102 allows those devices to take action by triggering the dispatch of aICM 12 to thepatient 10, even though the data recorded by thesensor 104 ordevice 102 is itself generally medically-insufficient for purposes of diagnosis and care. Thus, rather than passively recording patient data, thesensor 104 ordevice 102 takes on an active role in initiating the provisioning of medical care to thepatient 10 and starts a cascade of appropriate medical interventions under the tutelage of and followed by physicians and trained healthcare professionals. - In a still further embodiment, based upon machine learning instructions executed by the
ICM 12 that generates alerts over health conditions or arrhythmias of selected medical concern, theICM 12 could upload an event detection application to thesensor 104 ordevice 102 to enable those devices to detect those types of potentially medically-significant events. Alternatively, the event detection application could be downloaded to thesensor 104 ordevice 102 from an online application store or similar online application repository. Finally, theICM 12 could use thesensor 104 ordevice 102 to generate an appropriate alert, including contacting the patient's physician or healthcare services, via wireless (or wired) communications, upon detecting a potentially medically-significant event or in response to a patient prompting. - The
mobile device 102 could also serve as a conduit for providing the data collected by the wearable physiology monitor oractivity sensor 104 to a server 122, or, similarly, the wearable physiology monitor oractivity sensor 104 could itself directly provide the collected data to the server 122. The server 122 could then merge the collected data into the wearer'sEMRs 134 in the secure database 124, if appropriate (and permissible), or the server 122 could perform an analysis of the collected data, perhaps based by comparison to a population of like wearers of the wearable physiology monitor oractivity sensor 104. Still other server 122 functions on the collected data are possible. - Finally, in a yet further embodiment, the
ICM 12 can be interrogated using a conventionalinductive programmer 100, which could be interfaced to theapplication program 98 executing on a physician's device, or in a standalone fashion. Inductive interfacing may be necessary where thetransceiver 85 has suffered an error condition or is otherwise unable to communicate externally. - The
ICM 12 continuously monitors the patient's ECG, heart rate and physiology over a long period of time lasting up to several years in duration.FIG. 10 is a flow diagram showing an ICM-implementedmethod 110 for monitoring ECG data. Initially, upon successful implantation, themicrocontroller 61 executes a power up sequence (step 111). During the power up sequence, the voltage of the battery is checked, the state of the flash memory 62 is confirmed, both in terms of operability check and available capacity, and microcontroller operation is diagnostically confirmed. - Following satisfactory completion of the power up sequence, an iterative processing loop (steps 112-121) is continually executed by the
microcontroller 61. During each iteration (step 112) of the processing loop, the ECG frontend 63 (shown inFIG. 11 ) continually senses the dermal ECG electrical signals (step 113,FIG. 10 ) via theECG electrodes microcontroller 61 by sampling the analog ECG signal that is output by the ECGfront end circuit 63. Each sampled ECG signal, in quantized and digitized form, is processed by signal processing modules as specified in firmware (step 115), as described infra, and temporarily staged in a buffer (step 116), pending compression preparatory to storage in the flash memory 62 (step 117). Following compression, the compressed ECG digitized sample is again buffered (step 118), then written to the flash memory 62 (step 119) using the communications bus. In a further embodiment, an alert that includes the compressed ECG digitized sample can also be wirelessly transmitted upon the triggering of a preset condition (step 120), such as an abnormally low heart rate in excess of 170 beats per minute (bpm), an abnormally low heart rate falling below 30 bpm, or AF detected by onboard analysis of RR interval variability by themicrocontroller 61. Processing continues for an indefinite duration (step 121). Still other operations and steps are possible. - The
microcontroller 61 operates under modular micro program control that includes processing of raw analog ECG signals.FIG. 11 is a functional block diagram showing thesignal processing functionality 130 of themicrocontroller 61. Themicrocontroller 61 operates under modular micro program control as specified infirmware 132. Thefirmware modules 132 include high andlow pass filtering 133, andcompression 134. Other modules are possible. Themicrocontroller 61 has a built-in ADC, although ADC functionality could also be provided in thefirmware 132. - The ECG
front end circuit 63 first outputs an analog ECG signal, which theADC 131 acquires, samples and converts into an uncompressed digital representation. Themicrocontroller 61 includes one ormore firmware modules 133 that perform filtering. In one embodiment, three low pass filters and two high pass filters are used. Following filtering, the digital representation of the cardiac activation wave front amplitudes are compressed by acompression module 134 before being written out tostorage 135. - The download station 92 (shown in
FIG. 9 ) executes a data link program (“DL”) 93 or similar program that wirelessly interfaces with theILR 12 to retrieve the stored ECG monitoring data and perform other functions.FIG. 12 is a functional block diagram showing theoperations 140 performed by thedownload station 141. Thedownload station 141 could be a server, personal computer (as shown), tablet or handheld computer, smart mobile device, or purpose-built programmer designed specific to the task of wirelessly interfacing with aICM 12. Still other forms of download station are possible, including download stations connected through indirect wireless interfacing using, for instance, a smart phone connected to theICM 12 through Bluetooth or Wi-Fi, or over an inductive coupling. - The
download station 141 is responsible for offloading stored ECG monitoring data from aICM 12. Thedownload station 141 operates under programmable control as specified in software. The stored ECG monitoring data remotely retrieved fromstorage 142 on aICM 12 is first decompressed by adecompression module 143, which converts the stored ECG monitoring data back into an uncompressed digital representation more suited to signal processing than a compressed signal. The retrieved ECG monitoring data may be stored into local storage (not shown) for archival purposes, either in original compressed form, or as uncompressed. - The
download station 141 can include an array of filtering modules. For instance, a set of phasedistortion filtering tools 144 may be provided, where corresponding software filters can be provided for each filter implemented in the firmware executed by themicrocontroller 61. The digital signals are run through the software filters in a reverse direction to remove phase distortion. For instance, a 45 Hertz high pass filter in firmware may have a matchingreverse 45 Hertz high pass filter in software. Most of the phase distortion is corrected, that is, canceled to eliminate noise at the set frequency, but data at other frequencies in the waveform remain unaltered. As well, bidirectional impulse infinite response (IIR) high pass filters and reverse direction (symmetric) IIR low pass filters can be provided. Data is run through these filters first in a forward direction, then in a reverse direction, which generates a square of the response and cancels out any phase distortion. This type of signal processing is particularly helpful with improving the display of the ST-segment by removing low frequency noise. - An automatic gain control (AGC)
module 145 can also be provided to adjust the digital signals to a usable level based on peak or average signal level or other metric. AGC is particularly critical to single-lead ECG monitors, where physical factors, such as the tilt of the heart, can affect the electrical field generated. On three-lead Holter monitors, the leads are oriented in vertical, horizontal and diagonal directions. As a result, the horizontal and diagonal leads may be higher amplitude and ECG interpretation will be based on one or both of the higher amplitude leads. In contrast, theICM 12 has only a single lead that is oriented in the vertical direction, so variations in amplitude will be wider than available with multi-lead monitors, which have alternate leads to fall back upon. - In addition, AGC may be necessary to maintain compatibility with existing ECG interpretation software, which is typically calibrated for multi-lead ECG monitors for viewing signals over a narrow range of amplitudes. Through the
AGC module 145, the gain of signals recorded by theICM 12 of the electrocardiography monitor 12 can be attenuated up (or down) to work with FDA-approved commercially available ECG interpretation. - AGC can be implemented in a fixed fashion that is uniformly applied to all signals in an ECG recording, adjusted as appropriate on a recording-by-recording basis. Typically, a fixed AGC value is calculated based on how an ECG recording is received to preserve the amplitude relationship between the signals. Alternatively, AGC can be varied dynamically throughout an ECG recording, where signals in different segments of an ECG recording are amplified up (or down) by differing amounts of gain.
- Typically, the
ICM 12 will record a high resolution, low frequency signal for the P-wave segment similar to the ICM's dermal cousin, such as provided with the dermal ambulatory monitors cited supra. However, for some patients, the result may still be a visually small signal. Although high resolution is present, the unaided eye will normally be unable to discern the P-wave segment. Therefore, gaining the signal is critical to visually depicting P-wave detail. This technique works most efficaciously with a raw signal with low noise and high resolution, as typically generated by theICM 12. Automatic gain control applied to a high noise signal will only exacerbate noise content and be self-defeating. - Finally, the download station can include filtering modules specifically intended to enhance P-wave content. For instance, a P-wave based
boost filter 146, which is a form of a pre-emphasis filter, can be applied to the signal to restore missing frequency content or to correct phase distortion. Still other filters and types of signal processing are possible. - In one embodiment, the
ICM 12 can simply be inserted with a small surgical incision that is the width of the widest part of the ICM, typically the transverse cross section of the thickest aspect of thehousing 15. Blunt dissection thereafter under local anesthesia can be used to create the subcutaneous space to receive theICM 12, which would generally be inserted into the implantation site, proximal (housing) end first, followed by the distal (electrode assembly) end. In a further embodiment, theICM 12 can be implanted in the patient's chest using, for instance, a minimally invasive subcutaneous implantation instrument, such as described in U.S. Pat. No. 6,436,068, issued Aug. 20, 2002 to Bardy, the disclosure of which is incorporated by reference. - While the invention has been particularly shown and described as referenced to the embodiments thereof, those skilled in the art will understand that the foregoing and other changes in form and detail may be made therein without departing from the spirit and scope.
Claims (17)
Priority Applications (17)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15/832,385 US20190167139A1 (en) | 2017-12-05 | 2017-12-05 | Subcutaneous P-Wave Centric Insertable Cardiac Monitor For Long Term Electrocardiographic Monitoring |
US16/178,455 US10624551B2 (en) | 2013-09-25 | 2018-11-01 | Insertable cardiac monitor for use in performing long term electrocardiographic monitoring |
US16/178,444 US10736529B2 (en) | 2013-09-25 | 2018-11-01 | Subcutaneous insertable electrocardiography monitor |
US16/178,468 US10736531B2 (en) | 2013-09-25 | 2018-11-01 | Subcutaneous insertable cardiac monitor optimized for long term, low amplitude electrocardiographic data collection |
US16/178,463 US10433751B2 (en) | 2013-09-25 | 2018-11-01 | System and method for facilitating a cardiac rhythm disorder diagnosis based on subcutaneous cardiac monitoring data |
EP18209920.0A EP3494871A1 (en) | 2017-12-05 | 2018-12-03 | Subcutaneous p-wave centric insertable cardiac monitor for long term electrocardiographic monitoring |
US16/595,226 US10813567B2 (en) | 2013-09-25 | 2019-10-07 | System and method for composite display of subcutaneous cardiac monitoring data |
US16/736,582 US10820801B2 (en) | 2013-09-25 | 2020-01-07 | Electrocardiography monitor configured for self-optimizing ECG data compression |
US16/853,667 US11660035B2 (en) | 2013-09-25 | 2020-04-20 | Insertable cardiac monitor |
US16/989,196 US11445965B2 (en) | 2013-09-25 | 2020-08-10 | Subcutaneous insertable cardiac monitor optimized for long-term electrocardiographic monitoring |
US17/080,757 US11445969B2 (en) | 2013-09-25 | 2020-10-26 | System and method for event-centered display of subcutaneous cardiac monitoring data |
US17/086,137 US11445908B2 (en) | 2013-09-25 | 2020-10-30 | Subcutaneous electrocardiography monitor configured for self-optimizing ECG data compression |
US17/686,335 US11678830B2 (en) | 2017-12-05 | 2022-03-03 | Noise-separating cardiac monitor |
US17/944,702 US11678799B2 (en) | 2013-09-25 | 2022-09-14 | Subcutaneous electrocardiography monitor configured for test-based data compression |
US17/944,899 US11653870B2 (en) | 2013-09-25 | 2022-09-14 | System and method for display of subcutaneous cardiac monitoring data |
US17/947,753 US11653868B2 (en) | 2013-09-25 | 2022-09-19 | Subcutaneous insertable cardiac monitor optimized for electrocardiographic (ECG) signal acquisition |
US18/320,820 US20230284958A1 (en) | 2013-09-25 | 2023-05-19 | Subcutaneous insertable cardiac monitor optimized for electrocardiographic (ecg) data acquisition and processing |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15/832,385 US20190167139A1 (en) | 2017-12-05 | 2017-12-05 | Subcutaneous P-Wave Centric Insertable Cardiac Monitor For Long Term Electrocardiographic Monitoring |
Related Parent Applications (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/231,752 Continuation US10045709B2 (en) | 2013-09-25 | 2016-08-08 | System and method for facilitating a cardiac rhythm disorder diagnosis with the aid of a digital computer |
US15/406,627 Continuation US9901274B2 (en) | 2013-09-25 | 2017-01-13 | Electrocardiography patch |
US15/483,142 Continuation US9955888B2 (en) | 2013-09-25 | 2017-04-10 | Ambulatory electrocardiography monitor recorder optimized for internal signal processing |
US15/676,896 Continuation-In-Part US10478083B2 (en) | 2013-09-25 | 2017-08-14 | Extended wear ambulatory electrocardiography and physiological sensor monitor |
US15/682,242 Continuation US10052022B2 (en) | 2013-09-25 | 2017-08-21 | System and method for providing dynamic gain over non-noise electrocardiographic data with the aid of a digital computer |
Related Child Applications (12)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/080,725 Continuation-In-Part US9730593B2 (en) | 2013-09-25 | 2013-11-14 | Extended wear ambulatory electrocardiography and physiological sensor monitor |
US14/080,717 Continuation-In-Part US9545204B2 (en) | 2013-09-25 | 2013-11-14 | Extended wear electrocardiography patch |
US15/905,715 Continuation-In-Part US11103173B2 (en) | 2013-09-25 | 2018-02-26 | Electrocardiography patch |
US15/966,910 Continuation-In-Part US10271756B2 (en) | 2013-09-25 | 2018-04-30 | Monitor recorder optimized for electrocardiographic signal processing |
US16/102,608 Continuation-In-Part US10736532B2 (en) | 2013-09-25 | 2018-08-13 | System and method for facilitating a cardiac rhythm disorder diagnosis with the aid of a digital computer |
US16/105,603 Continuation-In-Part US10499812B2 (en) | 2013-09-25 | 2018-08-20 | System and method for applying a uniform dynamic gain over cardiac data with the aid of a digital computer |
US16/178,455 Continuation-In-Part US10624551B2 (en) | 2013-09-25 | 2018-11-01 | Insertable cardiac monitor for use in performing long term electrocardiographic monitoring |
US16/178,468 Continuation-In-Part US10736531B2 (en) | 2013-09-25 | 2018-11-01 | Subcutaneous insertable cardiac monitor optimized for long term, low amplitude electrocardiographic data collection |
US16/178,463 Continuation-In-Part US10433751B2 (en) | 2013-09-25 | 2018-11-01 | System and method for facilitating a cardiac rhythm disorder diagnosis based on subcutaneous cardiac monitoring data |
US16/595,226 Continuation-In-Part US10813567B2 (en) | 2013-09-25 | 2019-10-07 | System and method for composite display of subcutaneous cardiac monitoring data |
US16/736,582 Continuation-In-Part US10820801B2 (en) | 2013-09-25 | 2020-01-07 | Electrocardiography monitor configured for self-optimizing ECG data compression |
US17/686,335 Continuation US11678830B2 (en) | 2017-12-05 | 2022-03-03 | Noise-separating cardiac monitor |
Publications (1)
Publication Number | Publication Date |
---|---|
US20190167139A1 true US20190167139A1 (en) | 2019-06-06 |
Family
ID=64572245
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/832,385 Abandoned US20190167139A1 (en) | 2013-09-25 | 2017-12-05 | Subcutaneous P-Wave Centric Insertable Cardiac Monitor For Long Term Electrocardiographic Monitoring |
US17/686,335 Active US11678830B2 (en) | 2017-12-05 | 2022-03-03 | Noise-separating cardiac monitor |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US17/686,335 Active US11678830B2 (en) | 2017-12-05 | 2022-03-03 | Noise-separating cardiac monitor |
Country Status (2)
Country | Link |
---|---|
US (2) | US20190167139A1 (en) |
EP (1) | EP3494871A1 (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2021030216A1 (en) | 2019-08-09 | 2021-02-18 | Bardy Diagnostics, Inc. | Facilitating a cardiac rhythm disorder diagnosis with the aid of a digital computer |
USD926989S1 (en) * | 2018-02-19 | 2021-08-03 | Socrates Health Solutions, Inc. | Pen device |
US11116451B2 (en) * | 2019-07-03 | 2021-09-14 | Bardy Diagnostics, Inc. | Subcutaneous P-wave centric insertable cardiac monitor with energy harvesting capabilities |
US20220061742A1 (en) * | 2020-08-28 | 2022-03-03 | Covidien Lp | Determining composite signals from at least three electrodes |
USD957639S1 (en) * | 2013-03-15 | 2022-07-12 | Medtronic, Inc. | Implantable cardiac monitor |
EP4027620A1 (en) | 2021-01-10 | 2022-07-13 | Bardy Diagnostics, Inc. | System and method for long-term patient monitoring of continuous ecg and physiological data |
US20230106359A1 (en) * | 2021-09-24 | 2023-04-06 | Biointellisense, Inc. | Multi-use ecg system |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2021163489A1 (en) * | 2020-02-13 | 2021-08-19 | Cardiac Pacemakers, Inc. | Implantable medical device having a biocompatible circuit board with embedded electrodes |
Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7294108B1 (en) * | 2005-01-27 | 2007-11-13 | Pacesetter, Inc. | Cardiac event microrecorder and method for implanting same |
US20090012412A1 (en) * | 2005-02-25 | 2009-01-08 | Joseph Wiesel | Detecting Atrial Fibrillation, Method of and Apparatus for |
US8108035B1 (en) * | 2006-10-18 | 2012-01-31 | Pacesetter, Inc. | Systems and methods for detecting and compensating for changes in posture during ischemia detection a using an implantable medical device |
US9345414B1 (en) * | 2013-09-25 | 2016-05-24 | Bardy Diagnostics, Inc. | Method for providing dynamic gain over electrocardiographic data with the aid of a digital computer |
US20170112399A1 (en) * | 2015-10-23 | 2017-04-27 | Cardiac Pacemakers, Inc. | Multi-vector sensing in cardiac devices using a hybrid approach |
US20170281032A1 (en) * | 2016-03-29 | 2017-10-05 | Pacestter, Inc. | Method and system to discriminate rhythm patterns in cardiac activity |
US20170281033A1 (en) * | 2016-03-30 | 2017-10-05 | Medtronic, Inc. | Atrial arrhythmia episode detection in a cardiac medical device |
US20170354365A1 (en) * | 2016-06-13 | 2017-12-14 | Medtronic, Inc. | Multi-parameter prediction of acute cardiac episodes and attacks |
US20170366921A1 (en) * | 2016-05-20 | 2017-12-21 | Pacesetter, Inc. | Dynamic Announcing For Creation Of Wireless Communication Connections |
US20180078771A1 (en) * | 2016-09-21 | 2018-03-22 | Cardiac Pacemakers, Inc. | Implantable cardiac monitor |
US20190336032A1 (en) * | 2018-05-07 | 2019-11-07 | Pacesetter, Inc. | Method and system to detect premature ventricular contractions in cardiac activity signals |
US20200038671A1 (en) * | 2018-07-31 | 2020-02-06 | Medtronic, Inc. | Wearable defibrillation apparatus configured to apply a machine learning algorithm |
Family Cites Families (521)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3215136A (en) | 1962-07-06 | 1965-11-02 | Holter Res Foundation Inc | Electrocardiographic means |
US3602215A (en) | 1968-09-16 | 1971-08-31 | Honeywell Inc | Electrode failure detection device |
US3569852A (en) | 1969-01-23 | 1971-03-09 | American Optical Corp | Frequency selective variable gain amplifier |
DE2123859A1 (en) | 1970-05-16 | 1971-12-02 | Jeol Ltd | Electrocardiograph |
US3718772A (en) | 1971-12-09 | 1973-02-27 | Del Mar Eng Lab | Dynamic egg presentation |
US3893453A (en) | 1974-02-11 | 1975-07-08 | American Optical Corp | Compressed data display system |
US4151513A (en) | 1975-03-06 | 1979-04-24 | Medtronic, Inc. | Apparatus for sensing and transmitting a pacemaker's stimulating pulse |
US4073011A (en) | 1976-08-25 | 1978-02-07 | Del Mar Avionics | Electrocardiographic computer |
US4532934A (en) | 1978-11-01 | 1985-08-06 | Del Mar Avionics | Pacemaker monitoring recorder and malfunction analyzer |
US4441500A (en) | 1980-04-17 | 1984-04-10 | Ferris Manufacturing Corp. | EKG Electrode |
US4328814A (en) | 1980-06-04 | 1982-05-11 | The Kendall Company | Precordial ECG strip |
US4506678A (en) | 1982-06-07 | 1985-03-26 | Healthdyne, Inc. | Patient monitor for providing respiration and electrocardiogram signals |
US4550502A (en) | 1983-04-15 | 1985-11-05 | Joseph Grayzel | Device for analysis of recorded electrocardiogram |
US4580572A (en) | 1983-06-01 | 1986-04-08 | Bio-Stimu Trend Corp. | Garment apparatus for delivering or receiving electric impulses |
FR2554704B1 (en) | 1983-11-10 | 1987-04-24 | Ascher Gilles | PORTABLE CARDIAC ACTIVITY MONITORING DEVICE |
US4546342A (en) | 1983-12-14 | 1985-10-08 | Digital Recording Research Limited Partnership | Data compression method and apparatus |
JPS6145733A (en) | 1984-08-09 | 1986-03-05 | 株式会社 建部青州堂 | Portable electrocardiograph memory apparatus |
FR2571603B1 (en) | 1984-10-11 | 1989-01-06 | Ascher Gilles | PORTABLE ELECTROCARDIOGRAM RECORDER |
US4788983A (en) | 1985-07-31 | 1988-12-06 | Brink Loren S | Pulse rate controlled entertainment device |
US4716903A (en) | 1986-10-06 | 1988-01-05 | Telectronics N.V. | Storage in a pacemaker memory |
US5007429A (en) | 1987-09-21 | 1991-04-16 | Pulsetrend, Inc. | Interface using 12-digit keypad for programming parameters in ambulatory blood pressure monitor |
US5025794A (en) | 1988-08-30 | 1991-06-25 | Corazonix Corporation | Method for analysis of electrocardiographic signal QRS complex |
US4915656A (en) | 1988-10-21 | 1990-04-10 | Physio-Control Corporation | Discriminating medical electrode connector |
US5511553A (en) | 1989-02-15 | 1996-04-30 | Segalowitz; Jacob | Device-system and method for monitoring multiple physiological parameters (MMPP) continuously and simultaneously |
NL8902613A (en) | 1989-10-23 | 1991-05-16 | Philips Nv | DEVICE FOR READING DIGITAL INFORMATION RECORDED ON AN INFORMATION CARRIER AND A PEAK DETECTOR AND AN INFORMATION CARRIER FOR SUCH A DEVICE. |
US5199432A (en) | 1990-10-30 | 1993-04-06 | American Home Products Corporation | Fetal electrode product for use in monitoring fetal heart rate |
USD341423S (en) | 1991-02-14 | 1993-11-16 | Chris Bible | Ambulatory cardiac monitor |
JP2655204B2 (en) | 1991-04-05 | 1997-09-17 | メドトロニック インコーポレーテッド | Implantable medical device |
US5341806A (en) | 1991-04-18 | 1994-08-30 | Physio-Control Corporation | Multiple electrode strip |
US6605046B1 (en) | 1991-06-03 | 2003-08-12 | Del Mar Medical Systems, Llc | Ambulatory physio-kinetic monitor with envelope enclosure |
US5365934A (en) | 1991-06-28 | 1994-11-22 | Life Fitness | Apparatus and method for measuring heart rate |
US5215098A (en) | 1991-08-12 | 1993-06-01 | Telectronics Pacing Systems, Inc. | Data compression of cardiac electrical signals using scanning correlation and temporal data compression |
US5191891A (en) | 1991-09-10 | 1993-03-09 | Ralin, Inc. | Portable ECG monitor/recorder |
US5353793A (en) | 1991-11-25 | 1994-10-11 | Oishi-Kogyo Company | Sensor apparatus |
US5314453A (en) | 1991-12-06 | 1994-05-24 | Spinal Cord Society | Position sensitive power transfer antenna |
GB9200586D0 (en) | 1992-01-13 | 1992-03-11 | Oxford Medical Ltd | Ecg analyzer |
US5956013A (en) | 1992-02-28 | 1999-09-21 | Hewlett-Packard Company | Method and apparatus for synchronizing a continuous ECG waveform display with a display of superimposed heartbeats |
US5263481A (en) | 1992-05-21 | 1993-11-23 | Jens Axelgaard | Electrode system with disposable gel |
US5333615A (en) | 1992-06-22 | 1994-08-02 | William Craelius | Apparatus for digitally recording and analyzing electrocardial and other bioelectric signals |
US5231990A (en) | 1992-07-09 | 1993-08-03 | Spacelabs, Medical, Inc. | Application specific integrated circuit for physiological monitoring |
US5312446A (en) | 1992-08-26 | 1994-05-17 | Medtronic, Inc. | Compressed storage of data in cardiac pacemakers |
US5265579A (en) | 1992-09-21 | 1993-11-30 | Ferrari R Keith | X-ray transparent monitoring electrode and method for making |
US5402884A (en) | 1992-09-24 | 1995-04-04 | Surviva Link Corporation | Medical electrode packaging technology |
US5984102A (en) | 1992-09-24 | 1999-11-16 | Survivalink Corporation | Medical electrode packaging technology |
US5297557A (en) | 1992-10-14 | 1994-03-29 | Del Mar Avionics | Stress test system with bidirectional filter |
US5450845A (en) | 1993-01-11 | 1995-09-19 | Axelgaard; Jens | Medical electrode system |
US5406955A (en) | 1993-03-12 | 1995-04-18 | Hewlett-Packard Corporation | ECG recorder and playback unit |
JPH06319711A (en) | 1993-05-13 | 1994-11-22 | Sharp Corp | Portable electrocardiograph |
US5473537A (en) | 1993-07-30 | 1995-12-05 | Psychresources Development Company | Method for evaluating and reviewing a patient's condition |
WO1995003739A1 (en) | 1993-08-03 | 1995-02-09 | Peter Walter Kamen | A method of measuring autonomic activity of a patient |
US5458141A (en) | 1993-08-04 | 1995-10-17 | Quinton Instrument Company | Abrasive skin electrode |
US5392784A (en) | 1993-08-20 | 1995-02-28 | Hewlett-Packard Company | Virtual right leg drive and augmented right leg drive circuits for common mode voltage reduction in ECG and EEG measurements |
USD357069S (en) | 1993-08-25 | 1995-04-04 | Quinton Instrument Company | Medical electrode |
US5402780A (en) | 1993-09-02 | 1995-04-04 | Faasse, Jr.; Adrian L. | Medical electrode with offset contact stud |
DE4329898A1 (en) | 1993-09-04 | 1995-04-06 | Marcus Dr Besson | Wireless medical diagnostic and monitoring device |
US5451876A (en) | 1993-10-18 | 1995-09-19 | General Electric Company | MRI system with dynamic receiver gain |
US6149781A (en) | 1994-01-10 | 2000-11-21 | Forand; James L. | Method and apparatus for electrochemical processing |
FR2722313B1 (en) | 1994-07-07 | 1997-04-25 | Ela Medical Sa | METHOD FOR COMPRESSING PHYSIOLOGICAL DATA, PARTICULARLY CARDIAC ACTIVATED, PARTICULARLY FOR HOLTER RECORDING OF ELECTROCARDIOGRAMS OR ELECTROGRAMS |
EP0700658B1 (en) | 1994-09-10 | 1999-11-03 | Hewlett-Packard GmbH | A device and a method for equalizing a patient's potential with respect to medical equipment |
US5540733A (en) | 1994-09-21 | 1996-07-30 | Medtronic, Inc. | Method and apparatus for detecting and treating obstructive sleep apnea |
US5549655A (en) | 1994-09-21 | 1996-08-27 | Medtronic, Inc. | Method and apparatus for synchronized treatment of obstructive sleep apnea |
US5483969A (en) | 1994-09-21 | 1996-01-16 | Medtronic, Inc. | Method and apparatus for providing a respiratory effort waveform for the treatment of obstructive sleep apnea |
US5546952A (en) | 1994-09-21 | 1996-08-20 | Medtronic, Inc. | Method and apparatus for detection of a respiratory waveform |
US6424860B1 (en) | 1994-10-07 | 2002-07-23 | Ortivus Ab | Myocardial ischemia and infarction analysis and monitoring method and apparatus |
US5520191A (en) | 1994-10-07 | 1996-05-28 | Ortivus Medical Ab | Myocardial ischemia and infarction analysis and monitoring method and apparatus |
US6038469A (en) | 1994-10-07 | 2000-03-14 | Ortivus Ab | Myocardial ischemia and infarction analysis and monitoring method and apparatus |
US8280682B2 (en) | 2000-12-15 | 2012-10-02 | Tvipr, Llc | Device for monitoring movement of shipped goods |
DE69530427T2 (en) | 1995-08-10 | 2004-03-04 | Pentavox Kft. | DEVICE FOR MEASURING THE FETAL HEART RATE |
USD377983S (en) | 1995-09-13 | 1997-02-11 | Mohamed Sabri | Cardiac monitor |
US5724967A (en) | 1995-11-21 | 1998-03-10 | Nellcor Puritan Bennett Incorporated | Noise reduction apparatus for low level analog signals |
US5697955A (en) | 1996-05-10 | 1997-12-16 | Survivalink Corporation | Defibrillator electrodes and date code detector circuit |
US5817151A (en) | 1996-06-04 | 1998-10-06 | Survivalink Corporation | Circuit detectable packaged medical electrodes |
US5749902A (en) | 1996-05-22 | 1998-05-12 | Survivalink Corporation | Recorded data correction method and apparatus for isolated clock systems |
US6101413A (en) | 1996-06-04 | 2000-08-08 | Survivalink Corporation | Circuit detectable pediatric defibrillation electrodes |
WO1998002209A2 (en) | 1996-07-11 | 1998-01-22 | Medtronic, Inc. | Minimally invasive implantable device for monitoring physiologic events |
US6149602A (en) | 1996-09-10 | 2000-11-21 | Arcelus; Almudena | User-worn electrocardiogram viewer device |
AUPO247496A0 (en) | 1996-09-23 | 1996-10-17 | Resmed Limited | Assisted ventilation to match patient respiratory need |
US6032064A (en) | 1996-10-11 | 2000-02-29 | Aspect Medical Systems, Inc. | Electrode array system for measuring electrophysiological signals |
US5860918A (en) | 1996-11-22 | 1999-01-19 | Hewlett-Packard Company | Representation of a review of a patent's physiological parameters |
US5951598A (en) | 1997-01-14 | 1999-09-14 | Heartstream, Inc. | Electrode system |
US5788633A (en) | 1997-01-28 | 1998-08-04 | Hewlett-Packard Company | ECG electrode strip with elongated slots |
EP1647300A3 (en) | 1997-02-26 | 2009-04-29 | The Alfred E Mann Foundation for Scientific Research | Battery-powered patient implantable device |
US6148233A (en) | 1997-03-07 | 2000-11-14 | Cardiac Science, Inc. | Defibrillation system having segmented electrodes |
US7756721B1 (en) | 1997-03-14 | 2010-07-13 | Best Doctors, Inc. | Health care management system |
JPH11188015A (en) | 1997-12-25 | 1999-07-13 | Suzuki Motor Corp | Biological signal measuring apparatus |
US5876351A (en) | 1997-04-10 | 1999-03-02 | Mitchell Rohde | Portable modular diagnostic medical device |
US5983127A (en) | 1997-05-21 | 1999-11-09 | Quinton Instruments Company | ECG noise detection system |
EP1859833A3 (en) | 1997-08-01 | 2008-07-02 | Harbinger Medical Inc. | System and method of non-invasively determining a patient's susceptibility to arrhythmia |
US5906583A (en) | 1997-08-20 | 1999-05-25 | R.Z. Comparative Diagnostics Ltd. | Automatic cardiometer |
US6381482B1 (en) | 1998-05-13 | 2002-04-30 | Georgia Tech Research Corp. | Fabric or garment with integrated flexible information infrastructure |
US20020013538A1 (en) | 1997-09-30 | 2002-01-31 | David Teller | Method and apparatus for health signs monitoring |
US6856832B1 (en) | 1997-12-25 | 2005-02-15 | Nihon Kohden Corporation | Biological signal detection apparatus Holter electrocardiograph and communication system of biological signals |
US6188407B1 (en) | 1998-03-04 | 2001-02-13 | Critikon Company, Llc | Reconfigurable user interface for modular patient monitor |
USD407159S (en) | 1998-04-30 | 1999-03-23 | Anne-Marie Roberg | Pre-natal heartbeat monitor |
US6115638A (en) | 1998-05-04 | 2000-09-05 | Survivalink Corporation | Medical electrode with conductive release liner |
US5957857A (en) | 1998-05-07 | 1999-09-28 | Cardiac Pacemakers, Inc. | Apparatus and method for automatic sensing threshold determination in cardiac pacemakers |
US6304773B1 (en) | 1998-05-21 | 2001-10-16 | Medtronic Physio-Control Manufacturing Corp. | Automatic detection and reporting of cardiac asystole |
US6246330B1 (en) | 1998-05-29 | 2001-06-12 | Wyn Y. Nielsen | Elimination-absorber monitoring system |
US6434410B1 (en) | 1998-06-19 | 2002-08-13 | Aspect Medical Systems, Inc. | Electrode for measuring electrophysiological signals using liquid electrolytic gel with a high salt concentration |
US6134479A (en) | 1998-07-09 | 2000-10-17 | Survivalink Corporation | Electrode triad for external defibrillation |
US6272385B1 (en) | 1998-09-01 | 2001-08-07 | Agilent Technologies, Inc. | Independently deployable sealed defibrillator electrode pad and method of use |
US6108578A (en) | 1998-09-02 | 2000-08-22 | Heartstream, Inc. | Configurable arrhythmia analysis algorithm |
US6970731B1 (en) | 1998-09-21 | 2005-11-29 | Georgia Tech Research Corp. | Fabric-based sensor for monitoring vital signs |
KR100658333B1 (en) | 1999-01-11 | 2006-12-14 | 비엠알 리서치 앤드 디벨럽먼트 리미티드 | An electrotherapy device and method |
US6249696B1 (en) | 1999-01-15 | 2001-06-19 | Medtronic Physio-Control Manufacturing Corp. | Method and apparatus for increasing the low frequency dynamic range of a digital ECG measuring system |
US6117077A (en) | 1999-01-22 | 2000-09-12 | Del Mar Medical Systems, Llc | Long-term, ambulatory physiological recorder |
US8636648B2 (en) | 1999-03-01 | 2014-01-28 | West View Research, Llc | Endoscopic smart probe |
US6416471B1 (en) | 1999-04-15 | 2002-07-09 | Nexan Limited | Portable remote patient telemonitoring system |
US6454708B1 (en) | 1999-04-15 | 2002-09-24 | Nexan Limited | Portable remote patient telemonitoring system using a memory card or smart card |
US6427085B1 (en) | 1999-05-11 | 2002-07-30 | Cardiac Pacemakers, Inc. | Cardiac sense amplifier for capture verification |
US6270457B1 (en) | 1999-06-03 | 2001-08-07 | Cardiac Intelligence Corp. | System and method for automated collection and analysis of regularly retrieved patient information for remote patient care |
US7134996B2 (en) | 1999-06-03 | 2006-11-14 | Cardiac Intelligence Corporation | System and method for collection and analysis of patient information for automated remote patient care |
US7429243B2 (en) | 1999-06-03 | 2008-09-30 | Cardiac Intelligence Corporation | System and method for transacting an automated patient communications session |
US6607485B2 (en) | 1999-06-03 | 2003-08-19 | Cardiac Intelligence Corporation | Computer readable storage medium containing code for automated collection and analysis of patient information retrieved from an implantable medical device for remote patient care |
US6312378B1 (en) | 1999-06-03 | 2001-11-06 | Cardiac Intelligence Corporation | System and method for automated collection and analysis of patient information retrieved from an implantable medical device for remote patient care |
US6298255B1 (en) | 1999-06-09 | 2001-10-02 | Aspect Medical Systems, Inc. | Smart electrophysiological sensor system with automatic authentication and validation and an interface for a smart electrophysiological sensor system |
FR2795300B1 (en) | 1999-06-23 | 2002-01-04 | Ela Medical Sa | HOLTER APPARATUS FOR RECORDING PHYSIOLOGICAL SIGNALS OF CARDIAC ACTIVITY |
CA2314517A1 (en) | 1999-07-26 | 2001-01-26 | Gust H. Bardy | System and method for determining a reference baseline of individual patient status for use in an automated collection and analysis patient care system |
CA2314513A1 (en) | 1999-07-26 | 2001-01-26 | Gust H. Bardy | System and method for providing normalized voice feedback from an individual patient in an automated collection and analysis patient care system |
US6221011B1 (en) | 1999-07-26 | 2001-04-24 | Cardiac Intelligence Corporation | System and method for determining a reference baseline of individual patient status for use in an automated collection and analysis patient care system |
US6304783B1 (en) | 1999-10-14 | 2001-10-16 | Heartstream, Inc. | Defibrillator system including a removable monitoring electrodes adapter and method of detecting the monitoring adapter |
US6398728B1 (en) | 1999-11-16 | 2002-06-04 | Cardiac Intelligence Corporation | Automated collection and analysis patient care system and method for diagnosing and monitoring respiratory insufficiency and outcomes thereof |
US8369937B2 (en) | 1999-11-16 | 2013-02-05 | Cardiac Pacemakers, Inc. | System and method for prioritizing medical conditions |
US6336903B1 (en) | 1999-11-16 | 2002-01-08 | Cardiac Intelligence Corp. | Automated collection and analysis patient care system and method for diagnosing and monitoring congestive heart failure and outcomes thereof |
US6368284B1 (en) | 1999-11-16 | 2002-04-09 | Cardiac Intelligence Corporation | Automated collection and analysis patient care system and method for diagnosing and monitoring myocardial ischemia and outcomes thereof |
US6411840B1 (en) | 1999-11-16 | 2002-06-25 | Cardiac Intelligence Corporation | Automated collection and analysis patient care system and method for diagnosing and monitoring the outcomes of atrial fibrillation |
US7085601B1 (en) | 1999-11-17 | 2006-08-01 | Koninklijke Philips Electronics N.V. | External atrial defibrillator and method for personal termination of atrial fibrillation |
DE19955211A1 (en) | 1999-11-17 | 2001-05-31 | Siemens Ag | Patient referral method for referring patient to other medical department |
US6912424B2 (en) | 1999-12-01 | 2005-06-28 | Meagan, Medical, Inc. | Apparatus and method for coupling therapeutic and/or monitoring equipment to a patient |
US6463320B1 (en) | 1999-12-22 | 2002-10-08 | Ge Medical Systems Information Technologies, Inc. | Clinical research workstation |
US20020026223A1 (en) | 1999-12-24 | 2002-02-28 | Riff Kenneth M. | Method and a system for using implanted medical device data for accessing therapies |
US6441747B1 (en) | 2000-04-18 | 2002-08-27 | Motorola, Inc. | Wireless system protocol for telemetry monitoring |
US6496721B1 (en) | 2000-04-28 | 2002-12-17 | Cardiac Pacemakers, Inc. | Automatic input impedance balancing for electrocardiogram (ECG) sensing applications |
US9183351B2 (en) | 2000-05-30 | 2015-11-10 | Vladimir Shusterman | Mobile system with network-distributed data processing for biomedical applications |
US20040049132A1 (en) | 2000-06-15 | 2004-03-11 | The Procter & Gamble Company | Device for body activity detection and processing |
US20030028811A1 (en) | 2000-07-12 | 2003-02-06 | Walker John David | Method, apparatus and system for authenticating fingerprints, and communicating and processing commands and information based on the fingerprint authentication |
US6895261B1 (en) | 2000-07-13 | 2005-05-17 | Thomas R. Palamides | Portable, wireless communication apparatus integrated with garment |
CA2414309C (en) | 2000-07-18 | 2006-10-31 | Motorola, Inc. | Wireless electrocardiograph system and method |
JP2002041544A (en) | 2000-07-25 | 2002-02-08 | Toshiba Corp | Text information analyzing device |
WO2002017593A2 (en) | 2000-08-22 | 2002-02-28 | Medtronics, Inc. | Medical device systems implemented network system for remote patient management |
US6436068B1 (en) | 2000-08-24 | 2002-08-20 | Gust H. Bardy | Instrument for implanting sensors and solid materials in a subcutaneous location and method thereof |
USD443063S1 (en) | 2000-08-25 | 2001-05-29 | Nexan Limited | Chest multisensor array |
USD445507S1 (en) | 2000-08-25 | 2001-07-24 | Nexan Limited | Electronics unit for chest multisensor array |
AU2001288989A1 (en) | 2000-09-08 | 2002-03-22 | Wireless Medical, Inc. | Cardiopulmonary monitoring |
US6647292B1 (en) | 2000-09-18 | 2003-11-11 | Cameron Health | Unitary subcutaneous only implantable cardioverter-defibrillator and optional pacer |
US6665559B2 (en) | 2000-10-06 | 2003-12-16 | Ge Medical Systems Information Technologies, Inc. | Method and apparatus for perioperative assessment of cardiovascular risk |
US20060100530A1 (en) | 2000-11-28 | 2006-05-11 | Allez Physionix Limited | Systems and methods for non-invasive detection and monitoring of cardiac and blood parameters |
US6754523B2 (en) | 2000-11-28 | 2004-06-22 | J. Gerald Toole | Method of analysis of the electrocardiogram |
US20020013717A1 (en) | 2000-12-28 | 2002-01-31 | Masahiro Ando | Exercise body monitor with functions to verify individual policy holder and wear of the same, and a business model for a discounted insurance premium for policy holder wearing the same |
US7412395B2 (en) | 2000-12-29 | 2008-08-12 | Ge Medical Systems Information Technologies, Inc. | Automated scheduling of emergency procedure based on identification of high-risk patient |
DE10104451B4 (en) | 2001-02-01 | 2006-10-05 | Siemens Ag | Device for carrying out a physiologically controlled measurement on a living being |
WO2002075584A1 (en) | 2001-03-19 | 2002-09-26 | B.S.P. Biological Signal Processing Ltd. | Apparatus and method for efficient representation of periodic and nearly periodic signals for analysis |
US6719689B2 (en) | 2001-04-30 | 2004-04-13 | Medtronic, Inc. | Method and system for compressing and storing data in a medical device having limited storage |
US20020184055A1 (en) | 2001-05-29 | 2002-12-05 | Morteza Naghavi | System and method for healthcare specific operating system |
US7221279B2 (en) | 2001-06-11 | 2007-05-22 | Nielsen Wyn Y | Elimination—absorber monitoring system |
US6671547B2 (en) | 2001-06-13 | 2003-12-30 | Koninklijke Philips Electronics N.V. | Adaptive analysis method for an electrotherapy device and apparatus |
US7933642B2 (en) | 2001-07-17 | 2011-04-26 | Rud Istvan | Wireless ECG system |
US7257438B2 (en) | 2002-07-23 | 2007-08-14 | Datascope Investment Corp. | Patient-worn medical monitoring device |
US6456256B1 (en) | 2001-08-03 | 2002-09-24 | Cardiac Pacemakers, Inc. | Circumferential antenna for an implantable medical device |
US6782293B2 (en) | 2001-09-14 | 2004-08-24 | Zoll Medical Corporation | Defibrillation electrode assembly including CPR pad |
US20090182204A1 (en) | 2001-10-04 | 2009-07-16 | Semler Herbert J | Body composition, circulation, and vital signs monitor and method |
US20050101875A1 (en) | 2001-10-04 | 2005-05-12 | Right Corporation | Non-invasive body composition monitor, system and method |
AUPR823701A0 (en) | 2001-10-12 | 2001-11-08 | Studico Pty Ltd | Service provider selection and management system |
US6755795B2 (en) | 2001-10-26 | 2004-06-29 | Koninklijke Philips Electronics N.V. | Selectively applied wearable medical sensors |
US20030083559A1 (en) | 2001-10-31 | 2003-05-01 | Thompson David L. | Non-contact monitor |
JP3817163B2 (en) | 2001-11-16 | 2006-08-30 | 株式会社パラマ・テック | Portable biological data measuring device |
US20030149349A1 (en) | 2001-12-18 | 2003-08-07 | Jensen Thomas P. | Integral patch type electronic physiological sensor |
US6719701B2 (en) | 2002-01-28 | 2004-04-13 | Pacesetter, Inc. | Implantable syncope monitor and method of using the same |
AU2003201616A1 (en) | 2002-02-07 | 2003-09-02 | Ecole Polytechnique Federale De Lausanne (Epfl) | Body movement monitoring device |
US6993377B2 (en) | 2002-02-22 | 2006-01-31 | The Board Of Trustees Of The University Of Arkansas | Method for diagnosing heart disease, predicting sudden death, and analyzing treatment response using multifractal analysis |
US6778852B2 (en) | 2002-03-14 | 2004-08-17 | Inovise Medical, Inc. | Color-coded ECG |
US7016529B2 (en) | 2002-03-15 | 2006-03-21 | Microsoft Corporation | System and method facilitating pattern recognition |
US6978169B1 (en) | 2002-04-04 | 2005-12-20 | Guerra Jim J | Personal physiograph |
US20040034284A1 (en) | 2002-04-10 | 2004-02-19 | Aversano Thomas R. | Patient initiated emergency response system |
US7027864B2 (en) | 2002-04-17 | 2006-04-11 | Koninklijke Philips Electronics N.V. | Defibrillation system and method designed for rapid attachment |
US7065401B2 (en) | 2002-05-08 | 2006-06-20 | Michael Worden | Method of applying electrical signals to a patient and automatic wearable external defibrillator |
US7144830B2 (en) | 2002-05-10 | 2006-12-05 | Sarnoff Corporation | Plural layer woven electronic textile, article and method |
US7277752B2 (en) | 2002-06-11 | 2007-10-02 | Matos Jeffrey A | System for cardiac resuscitation |
US20040008123A1 (en) | 2002-07-15 | 2004-01-15 | Battelle Memorial Institute | System and method for tracking medical devices |
US7020508B2 (en) | 2002-08-22 | 2006-03-28 | Bodymedia, Inc. | Apparatus for detecting human physiological and contextual information |
US7027858B2 (en) | 2002-09-11 | 2006-04-11 | Medtronic, Inc. | Methods and apparatus for cardiac R-wave sensing in a subcutaneous ECG waveform |
JP2004129788A (en) | 2002-10-09 | 2004-04-30 | Nippon Koden Corp | Device for processing biological information |
US7292977B2 (en) | 2002-10-17 | 2007-11-06 | Bbnt Solutions Llc | Systems and methods for providing online fast speaker adaptation in speech recognition |
US20040087836A1 (en) | 2002-10-31 | 2004-05-06 | Green Michael R. | Computer system and method for closed-loop support of patient self-testing |
US7433736B2 (en) | 2002-10-31 | 2008-10-07 | Medtronic, Inc. | Atrial capture detection via atrial-ventricular conduction |
US8332233B2 (en) | 2002-11-13 | 2012-12-11 | Biomedical Systems Corporation | Method and system for collecting and analyzing holter data employing a web site |
AT412756B (en) | 2002-12-13 | 2005-07-25 | Leonhard Lang Kg | MEDICAL ELECTRODE |
US8672852B2 (en) | 2002-12-13 | 2014-03-18 | Intercure Ltd. | Apparatus and method for beneficial modification of biorhythmic activity |
US7052472B1 (en) | 2002-12-18 | 2006-05-30 | Dsp Diabetes Sentry Products, Inc. | Systems and methods for detecting symptoms of hypoglycemia |
US7248688B2 (en) | 2003-01-27 | 2007-07-24 | Bellsouth Intellectual Property Corporation | Virtual physician office systems and methods |
US20050058701A1 (en) | 2003-01-29 | 2005-03-17 | Yossi Gross | Active drug delivery in the gastrointestinal tract |
US7035684B2 (en) | 2003-02-26 | 2006-04-25 | Medtronic, Inc. | Method and apparatus for monitoring heart function in a subcutaneously implanted device |
US20040236202A1 (en) | 2003-05-22 | 2004-11-25 | Burton Steven Angell | Expandable strap for use in electrical impedance tomography |
US20040243435A1 (en) | 2003-05-29 | 2004-12-02 | Med-Sched, Inc. | Medical information management system |
JP2005000409A (en) | 2003-06-12 | 2005-01-06 | Omron Healthcare Co Ltd | Electrocardiograph and display method for electrocardiographic complex |
US20040260188A1 (en) | 2003-06-17 | 2004-12-23 | The General Hospital Corporation | Automated auscultation system |
US7267278B2 (en) | 2003-06-23 | 2007-09-11 | Robert Lammle | Method and system for providing pharmaceutical product information to a patient |
US20050020889A1 (en) | 2003-07-24 | 2005-01-27 | Garboski Dennis P. | Medical monitoring system |
US7510531B2 (en) | 2003-09-18 | 2009-03-31 | Cardiac Pacemakers, Inc. | System and method for discrimination of central and obstructive disordered breathing events |
US20070185390A1 (en) | 2003-08-19 | 2007-08-09 | Welch Allyn, Inc. | Information workflow for a medical diagnostic workstation |
US20050043640A1 (en) | 2003-08-21 | 2005-02-24 | Chang Alexander C. | Remote electrocardiogram for early detection of coronary heart disease |
EP1681010B1 (en) | 2003-10-27 | 2012-10-10 | Olympus Corporation | Capsule type medical device |
US8626262B2 (en) | 2003-10-30 | 2014-01-07 | Halthion Medical Technologies, Inc. | Physiological data collection system |
US8620402B2 (en) | 2003-10-30 | 2013-12-31 | Halthion Medical Technologies, Inc. | Physiological sensor device |
WO2005046433A2 (en) | 2003-11-04 | 2005-05-26 | General Hospital Corporation | Life sign detection and health state assessment system |
US20050113661A1 (en) | 2003-11-21 | 2005-05-26 | Alireza Nazeri | EKG recording accessory system (EKG RAS) |
US7242978B2 (en) | 2003-12-03 | 2007-07-10 | Medtronic, Inc. | Method and apparatus for generating a template for arrhythmia detection and electrogram morphology classification |
US7301451B2 (en) | 2003-12-31 | 2007-11-27 | Ge Medical Systems Information Technologies, Inc. | Notification alarm transfer methods, system, and device |
WO2005092177A1 (en) | 2004-03-22 | 2005-10-06 | Bodymedia, Inc. | Non-invasive temperature monitoring device |
EP1731094B1 (en) | 2004-03-24 | 2014-02-26 | Nihon Kohden Corporation | Garment with a respiratory information analysis device |
WO2005094498A2 (en) | 2004-03-24 | 2005-10-13 | Noninvasive Medical Technologies, Llc | Thoracic impedance monitor and electrode array and method of use |
US7167744B2 (en) | 2004-03-30 | 2007-01-23 | Cardiac Science Corporation | Methods for quantifying the morphology and amplitude of cardiac action potential alternans |
WO2005112749A1 (en) | 2004-05-12 | 2005-12-01 | Zoll Medical Corporation | Ecg rhythm advisory method |
US7565194B2 (en) | 2004-05-12 | 2009-07-21 | Zoll Medical Corporation | ECG rhythm advisory method |
KR100592934B1 (en) | 2004-05-21 | 2006-06-23 | 한국전자통신연구원 | Wearable physiological signal detection module and measurement apparatus with the same |
US7715905B2 (en) | 2004-05-25 | 2010-05-11 | United Therapeutics Corporation | Cooperative processing with mobile monitoring device and computer system |
US7173437B2 (en) | 2004-06-10 | 2007-02-06 | Quantum Applied Science And Research, Inc. | Garment incorporating embedded physiological sensors |
US7761167B2 (en) | 2004-06-10 | 2010-07-20 | Medtronic Urinary Solutions, Inc. | Systems and methods for clinician control of stimulation systems |
WO2006009767A1 (en) | 2004-06-18 | 2006-01-26 | Neuronetrix, Inc | Wireless electrode for biopotential measurement |
DE102004030261A1 (en) | 2004-06-23 | 2006-01-19 | Deutsche Institute für Textil- und Faserforschung (DITF) | Garment with integrated sensors |
WO2006006158A1 (en) | 2004-07-09 | 2006-01-19 | Aerotel Medical Systems (1998) Ltd. | Wearable device, system and method for measuring vital parameters |
US20060030781A1 (en) | 2004-08-05 | 2006-02-09 | Adnan Shennib | Emergency heart sensor patch |
US7890180B2 (en) | 2004-08-09 | 2011-02-15 | Cardiac Pacemakers, Inc. | Secure remote access for an implantable medical device |
US20070299325A1 (en) | 2004-08-20 | 2007-12-27 | Brian Farrell | Physiological status monitoring system |
US7343198B2 (en) | 2004-08-23 | 2008-03-11 | The University Of Texas At Arlington | System, software, and method for detection of sleep-disordered breathing using an electrocardiogram |
US7546975B2 (en) | 2004-09-14 | 2009-06-16 | The Boeing Company | Tandem rotor wing rotational position control system |
US8172761B1 (en) | 2004-09-28 | 2012-05-08 | Impact Sports Technologies, Inc. | Monitoring device with an accelerometer, method and system |
WO2006045065A2 (en) | 2004-10-19 | 2006-04-27 | University Of Washington | Long-term monitoring for detection of atrial fibrillation |
US20070050209A1 (en) | 2004-11-08 | 2007-03-01 | Paul Yered | Method for Providing Prescriptions and Additional Services at Lower Costs Using an Ethnic and Demographic Prescription Program |
US20060111943A1 (en) | 2004-11-15 | 2006-05-25 | Wu Harry C | Method and system to edit and analyze longitudinal personal health data using a web-based application |
US20060122469A1 (en) | 2004-11-16 | 2006-06-08 | Martel Normand M | Remote medical monitoring system |
IL165232A0 (en) | 2004-11-16 | 2005-12-18 | Tapuz Medical Technologies T M | An ergometry belt |
US7570989B2 (en) | 2004-11-22 | 2009-08-04 | Cardiodynamics International Corporation | Method and apparatus for signal assessment including event rejection |
US7191803B2 (en) | 2004-12-13 | 2007-03-20 | Woven Electronics Corporation | Elastic fabric with sinusoidally disposed wires |
US7996072B2 (en) | 2004-12-21 | 2011-08-09 | Cardiac Pacemakers, Inc. | Positionally adaptable implantable cardiac device |
US8103335B2 (en) | 2004-12-22 | 2012-01-24 | Nihon Kohden Corporation | Cardiogram waveform correcting and displaying device and a method of correcting and displaying cardiogram waveforms |
JP4731936B2 (en) | 2005-02-09 | 2011-07-27 | 本田技研工業株式会社 | Rotary variable resistor |
WO2006100676A2 (en) | 2005-03-21 | 2006-09-28 | Health-Smart Limited | System for continuous blood pressure monitoring |
US20060224072A1 (en) | 2005-03-31 | 2006-10-05 | Cardiovu, Inc. | Disposable extended wear heart monitor patch |
US20060229522A1 (en) | 2005-04-08 | 2006-10-12 | Exelys, Llc | Portable cardiac monitor including RF communication |
SI1889198T1 (en) | 2005-04-28 | 2015-02-27 | Proteus Digital Health, Inc. | Pharma-informatics system |
US8688189B2 (en) | 2005-05-17 | 2014-04-01 | Adnan Shennib | Programmable ECG sensor patch |
US20070003115A1 (en) | 2005-06-30 | 2007-01-04 | Eastman Kodak Company | Remote diagnostic device for medical testing |
JP5714210B2 (en) | 2005-09-01 | 2015-05-07 | プロテウス デジタル ヘルス, インコーポレイテッド | Implantable wireless communication system |
JP4738958B2 (en) | 2005-09-26 | 2011-08-03 | 学校法人立命館 | ECG measurement device |
GB2420628B (en) | 2005-09-27 | 2006-11-01 | Toumaz Technology Ltd | Monitoring method and apparatus |
US20070078324A1 (en) | 2005-09-30 | 2007-04-05 | Textronics, Inc. | Physiological Monitoring Wearable Having Three Electrodes |
US20070078353A1 (en) | 2005-10-04 | 2007-04-05 | Welch Allyn, Inc. | Method and apparatus for removing baseline wander from an ECG signal |
US20070088419A1 (en) | 2005-10-13 | 2007-04-19 | Fiorina Mark A | Conductive pad assembly for electrical therapy device |
US20070093719A1 (en) | 2005-10-20 | 2007-04-26 | Nichols Allen B Jr | Personal heart rhythm recording device |
US20070089800A1 (en) | 2005-10-24 | 2007-04-26 | Sensatex, Inc. | Fabrics and Garments with Information Infrastructure |
US7657307B2 (en) | 2005-10-31 | 2010-02-02 | Medtronic, Inc. | Method of and apparatus for classifying arrhythmias using scatter plot analysis |
US8545416B1 (en) | 2005-11-04 | 2013-10-01 | Cleveland Medical Devices Inc. | Integrated diagnostic and therapeutic system and method for improving treatment of subject with complex and central sleep apnea |
US20070123801A1 (en) | 2005-11-28 | 2007-05-31 | Daniel Goldberger | Wearable, programmable automated blood testing system |
US20080288026A1 (en) | 2005-11-30 | 2008-11-20 | Koninklijke Philips Electronics N. V. | Electro-Mechanical Connector for Thin Medical Monitoring Patch |
KR100759948B1 (en) | 2005-12-08 | 2007-09-19 | 한국전자통신연구원 | Garment apparatus for measuring physiological signal |
EP1959832A2 (en) | 2005-12-08 | 2008-08-27 | Koninklijke Philips Electronics N.V. | Medical sensor having electrodes and a motion sensor |
US20070136091A1 (en) | 2005-12-13 | 2007-06-14 | Mctaggart Ryan | Method and system for patient transfers and referrals |
US7815809B2 (en) | 2005-12-13 | 2010-10-19 | Gambro Lundia Ab | Method for conductivity calculation in a treatment fluid upstream and downstream a filtration unit in apparatuses for the blood treatment |
WO2007092543A2 (en) | 2006-02-06 | 2007-08-16 | The Board Of Trustees Of The Leland Stanford Junior University | Non-invasive cardiac monitor and methods of using continuously recorded cardiac data |
CN101420904A (en) | 2006-03-03 | 2009-04-29 | 心脏科学公司 | Methods for quantifying the risk of cardiac death using exercise induced heart rate variability metrics |
US8200320B2 (en) | 2006-03-03 | 2012-06-12 | PhysioWave, Inc. | Integrated physiologic monitoring systems and methods |
US20070208232A1 (en) | 2006-03-03 | 2007-09-06 | Physiowave Inc. | Physiologic monitoring initialization systems and methods |
USD558882S1 (en) | 2006-03-14 | 2008-01-01 | Unomedical Limited | Biomedical electrode for attachment to skin |
US7761150B2 (en) * | 2006-03-29 | 2010-07-20 | Medtronic, Inc. | Method and apparatus for detecting arrhythmias in a medical device |
US7702382B2 (en) | 2006-04-17 | 2010-04-20 | General Electric Company | Multi-tier system for cardiology and patient monitoring data analysis |
US7558622B2 (en) | 2006-05-24 | 2009-07-07 | Bao Tran | Mesh network stroke monitoring appliance |
US7539533B2 (en) | 2006-05-16 | 2009-05-26 | Bao Tran | Mesh network monitoring appliance |
GB0610292D0 (en) | 2006-05-24 | 2006-07-05 | Melys Diagnostics Ltd | Heart monitor |
US20070276275A1 (en) | 2006-05-24 | 2007-11-29 | University Of Miami | Screening method and system to estimate the severity of injury in critically ill patients |
US8781568B2 (en) | 2006-06-23 | 2014-07-15 | Brian M. Dugan | Systems and methods for heart rate monitoring, data transmission, and use |
US20070299617A1 (en) | 2006-06-27 | 2007-12-27 | Willis John P | Biofouling self-compensating biosensor |
WO2008010215A2 (en) | 2006-07-18 | 2008-01-24 | Biopad Ltd | Fetal wellbeing monitoring apparatus and pad therefor |
WO2008010216A2 (en) | 2006-07-18 | 2008-01-24 | Biopad Ltd | Fetal motor activity monitoring apparatus and pad therfor |
US8073740B1 (en) | 2006-08-15 | 2011-12-06 | Amazon Technologies, Inc. | Facilitating a supply of used items |
US7880626B2 (en) | 2006-10-12 | 2011-02-01 | Masimo Corporation | System and method for monitoring the life of a physiological sensor |
US20080091089A1 (en) | 2006-10-12 | 2008-04-17 | Kenneth Shane Guillory | Single use, self-contained surface physiological monitor |
US7878030B2 (en) | 2006-10-27 | 2011-02-01 | Textronics, Inc. | Wearable article with band portion adapted to include textile-based electrodes and method of making such article |
US8214007B2 (en) | 2006-11-01 | 2012-07-03 | Welch Allyn, Inc. | Body worn physiological sensor device having a disposable electrode module |
TW200820938A (en) | 2006-11-07 | 2008-05-16 | Leadtek Research Inc | Physiological data measuring device and measuring patch |
CN101534708A (en) | 2006-11-10 | 2009-09-16 | 皇家飞利浦电子股份有限公司 | ECG electrode contact quality measurement system |
US8180425B2 (en) | 2006-12-05 | 2012-05-15 | Tyco Healthcare Group Lp | ECG lead wire organizer and dispenser |
CN101547635B (en) | 2006-12-07 | 2011-09-14 | 皇家飞利浦电子股份有限公司 | Handheld, repositionable ECG detector |
EP2109397B1 (en) | 2007-01-25 | 2020-02-19 | LifeSync Corporation | Radiolucent assembly for connecting electrode or sensor |
US8858432B2 (en) | 2007-02-01 | 2014-10-14 | Proteus Digital Health, Inc. | Ingestible event marker systems |
US20090093687A1 (en) | 2007-03-08 | 2009-04-09 | Telfort Valery G | Systems and methods for determining a physiological condition using an acoustic monitor |
US7429938B1 (en) | 2007-03-26 | 2008-09-30 | Medtronic, Inc. | Method of compressing waveform data with differential entropy based compression |
US20080243012A1 (en) | 2007-03-29 | 2008-10-02 | Nihon Kohden Corporation | Method of compressing electrocardiogram data and electrocardiogram telemetry system using the same |
US20090327715A1 (en) | 2007-05-04 | 2009-12-31 | Smith Kevin W | System and Method for Cryptographic Identification of Interchangeable Parts |
US20080294024A1 (en) | 2007-05-24 | 2008-11-27 | Cosentino Daniel L | Glucose meter system and monitor |
WO2009055415A2 (en) | 2007-10-24 | 2009-04-30 | Hmicro, Inc. | A flexible wireless patch for physiological monitoring and methods of manufacturing the same |
FI20075426A0 (en) | 2007-06-08 | 2007-06-08 | Polar Electro Oy | Performance meter, transmission method and computer program product |
US8060175B2 (en) | 2007-06-15 | 2011-11-15 | General Electric Company | System and apparatus for collecting physiological signals from a plurality of electrodes |
JP5213097B2 (en) | 2007-06-15 | 2013-06-19 | 株式会社日立製作所 | Sensor node and sensor network system |
US7783648B2 (en) | 2007-07-02 | 2010-08-24 | Teradata Us, Inc. | Methods and systems for partitioning datasets |
US7706870B2 (en) | 2007-07-10 | 2010-04-27 | Yuan Ze University | Method for analyzing irreversible apneic coma (IAC) |
KR100895300B1 (en) | 2007-07-20 | 2009-05-07 | 한국전자통신연구원 | Arment for physiological signal measurement and system for processing physiological signal |
US7787943B2 (en) | 2007-07-25 | 2010-08-31 | Mcdonough Daniel K | Heart rate monitor for swimmers |
CN101854852A (en) | 2007-07-26 | 2010-10-06 | 皇家飞利浦电子股份有限公司 | Be used to obtain the electrode of experimenter's physiological signal |
KR100863064B1 (en) | 2007-08-03 | 2008-10-13 | 한국전자통신연구원 | Garment for measuring physiological signals and method of fabricating the same |
US8467880B2 (en) | 2007-08-23 | 2013-06-18 | Bioness Inc. | System for transmitting electrical current to a bodily tissue |
US20090062670A1 (en) | 2007-08-30 | 2009-03-05 | Gary James Sterling | Heart monitoring body patch and system |
US9072884B2 (en) | 2007-09-04 | 2015-07-07 | Axelgaard Manufacturing Company, Ltd. | Differential diameter electrode |
WO2009036333A1 (en) | 2007-09-14 | 2009-03-19 | Corventis, Inc. | Dynamic pairing of patients to data collection gateways |
US8249686B2 (en) | 2007-09-14 | 2012-08-21 | Corventis, Inc. | Adherent device for sleep disordered breathing |
WO2009036348A1 (en) | 2007-09-14 | 2009-03-19 | Corventis, Inc. | Medical device automatic start-up upon contact to patient tissue |
EP2194847A1 (en) | 2007-09-14 | 2010-06-16 | Corventis, Inc. | Adherent device with multiple physiological sensors |
US20090076350A1 (en) | 2007-09-14 | 2009-03-19 | Corventis, Inc. | Data Collection in a Multi-Sensor Patient Monitor |
US20090076342A1 (en) | 2007-09-14 | 2009-03-19 | Corventis, Inc. | Adherent Multi-Sensor Device with Empathic Monitoring |
US20090076559A1 (en) | 2007-09-14 | 2009-03-19 | Corventis, Inc. | Adherent Device for Cardiac Rhythm Management |
US8684925B2 (en) | 2007-09-14 | 2014-04-01 | Corventis, Inc. | Injectable device for physiological monitoring |
US8374688B2 (en) | 2007-09-14 | 2013-02-12 | Corventis, Inc. | System and methods for wireless body fluid monitoring |
US8460189B2 (en) | 2007-09-14 | 2013-06-11 | Corventis, Inc. | Adherent cardiac monitor with advanced sensing capabilities |
US20090076397A1 (en) | 2007-09-14 | 2009-03-19 | Corventis, Inc. | Adherent Emergency Patient Monitor |
US20090076341A1 (en) | 2007-09-14 | 2009-03-19 | Corventis, Inc. | Adherent Athletic Monitor |
US20090088652A1 (en) | 2007-09-28 | 2009-04-02 | Kathleen Tremblay | Physiological sensor placement and signal transmission device |
WO2009055205A1 (en) | 2007-10-24 | 2009-04-30 | Medtronic, Inc. | Remote calibration of an implantable patient sensor |
US8082160B2 (en) | 2007-10-26 | 2011-12-20 | Hill-Rom Services, Inc. | System and method for collection and communication of data from multiple patient care devices |
EP2214550A1 (en) | 2007-10-31 | 2010-08-11 | Emsense Corporation | Systems and methods providing distributed collection and centralized processing of physiological responses from viewers |
US8180442B2 (en) | 2007-12-14 | 2012-05-15 | Greatbatch Ltd. | Deriving patient activity information from sensed body electrical information |
US20110098583A1 (en) | 2009-09-15 | 2011-04-28 | Texas Instruments Incorporated | Heart monitors and processes with accelerometer motion artifact cancellation, and other electronic systems |
EP2262418B1 (en) | 2008-03-10 | 2019-07-17 | Koninklijke Philips N.V. | Watertight cardiac monitoring system |
EP2262420B1 (en) | 2008-03-10 | 2018-10-17 | Koninklijke Philips N.V. | Ecg monitoring system with a charging docking station |
US9615793B2 (en) | 2008-03-10 | 2017-04-11 | Koninklijke Philips N.V. | Continuous outpatient ECG monitoring system |
JP2011519583A (en) | 2008-03-10 | 2011-07-14 | コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ | Mobile phone terminal with cover for ECG monitoring system |
WO2009112979A1 (en) | 2008-03-10 | 2009-09-17 | Koninklijke Philips Electronics N.V. | Cellphone handset with a custom control program for an egg monitoring system |
WO2009112978A1 (en) | 2008-03-10 | 2009-09-17 | Koninklijke Philips Electronics N.V. | A method for refurbishing ecg monitoring systems |
JP5405500B2 (en) | 2008-03-12 | 2014-02-05 | コーヴェンティス,インク. | Predicting cardiac decompensation based on cardiac rhythm |
JP5211773B2 (en) | 2008-03-13 | 2013-06-12 | 株式会社デンソー | ECG waveform measuring device |
US7881785B2 (en) | 2008-03-26 | 2011-02-01 | Cardiac Science Corporation | Method and apparatus for defrosting a defibrillation electrode |
USD606656S1 (en) | 2008-04-04 | 2009-12-22 | Seiko Epson Corporation | Wrist watch type purse sensor |
US8412317B2 (en) | 2008-04-18 | 2013-04-02 | Corventis, Inc. | Method and apparatus to measure bioelectric impedance of patient tissue |
US7996070B2 (en) * | 2008-04-24 | 2011-08-09 | Medtronic, Inc. | Template matching method for monitoring of ECG morphology changes |
TWI472301B (en) | 2008-04-25 | 2015-02-11 | Taiwan Textile Res Inst | Sports clothes |
US20100234697A1 (en) | 2008-04-29 | 2010-09-16 | Lotus Magnus, Llc | Systems, devices, and methods for monitoring a subject |
US8700118B2 (en) | 2008-05-01 | 2014-04-15 | 3M Innovative Properties Company | Biomedical sensor system |
US9883809B2 (en) | 2008-05-01 | 2018-02-06 | Earlysense Ltd. | Monitoring, predicting and treating clinical episodes |
WO2009140291A2 (en) | 2008-05-13 | 2009-11-19 | Proteus Biomedical, Inc. | Continuous field tomography systems and methods of using the same |
US20090292194A1 (en) | 2008-05-23 | 2009-11-26 | Corventis, Inc. | Chiropractic Care Management Systems and Methods |
US8814811B2 (en) | 2008-05-23 | 2014-08-26 | Medtronic, Inc. | Fall detection algorithm utilizing a three-axis accelerometer |
US8688654B2 (en) | 2009-10-06 | 2014-04-01 | International Business Machines Corporation | Data compression algorithm selection and tiering |
US20100191310A1 (en) | 2008-07-29 | 2010-07-29 | Corventis, Inc. | Communication-Anchor Loop For Injectable Device |
WO2010025144A1 (en) | 2008-08-29 | 2010-03-04 | Corventis, Inc. | Method and apparatus for acute cardiac monitoring |
US9095274B2 (en) | 2008-08-31 | 2015-08-04 | Empire Technology Development Llc | Real time medical data analysis system |
US9026212B2 (en) | 2008-09-23 | 2015-05-05 | Incube Labs, Llc | Energy harvesting mechanism for medical devices |
CA2745638C (en) | 2008-12-02 | 2018-06-26 | Purdue Research Foundation | Radio transparent sensor implant package |
DE102008054442A1 (en) | 2008-12-10 | 2010-06-17 | Robert Bosch Gmbh | Procedures for remote diagnostic monitoring and support of patients as well as facility and telemedicine center |
EP2375968B1 (en) | 2008-12-15 | 2018-11-14 | Medtronic Monitoring, Inc. | Patient monitoring systems and methods |
US9439566B2 (en) | 2008-12-15 | 2016-09-13 | Proteus Digital Health, Inc. | Re-wearable wireless device |
TWI503101B (en) | 2008-12-15 | 2015-10-11 | Proteus Digital Health Inc | Body-associated receiver and method |
US8777895B2 (en) | 2009-01-06 | 2014-07-15 | Hospira, Inc. | System and method for authorized medication delivery |
US20100177100A1 (en) | 2009-01-09 | 2010-07-15 | Tony Carnes | System and method for customized display of physiological parameters |
WO2010104952A2 (en) | 2009-03-10 | 2010-09-16 | Corventis, Inc. | Display systems for body-worn health monitoring devices |
WO2010105045A2 (en) | 2009-03-11 | 2010-09-16 | Corventis, Inc. | Method and apparatus for fall prevention and monitoring |
US20100234716A1 (en) | 2009-03-12 | 2010-09-16 | Corventis, Inc. | Method and Apparatus for Monitoring Fluid Content within Body Tissues |
WO2010103164A1 (en) | 2009-03-13 | 2010-09-16 | Polar Electro Oy | Data transfer |
US9002427B2 (en) | 2009-03-30 | 2015-04-07 | Lifewave Biomedical, Inc. | Apparatus and method for continuous noninvasive measurement of respiratory function and events |
US8108311B2 (en) | 2009-04-09 | 2012-01-31 | General Electric Company | Systems and methods for constructing a local electronic medical record data store using a remote personal health record server |
US20100298720A1 (en) | 2009-04-16 | 2010-11-25 | Potkay Joseph Allen | In Situ Energy Harvesting Systems for Implanted Medical Devices |
US10588527B2 (en) | 2009-04-16 | 2020-03-17 | Braemar Manufacturing, Llc | Cardiac arrhythmia report |
US20100317957A1 (en) | 2009-06-16 | 2010-12-16 | Tex-Ray Industrial Co., Ltd. | Three-dimensional wearable electrode set |
US10085657B2 (en) | 2009-06-17 | 2018-10-02 | Sotera Wireless, Inc. | Body-worn pulse oximeter |
WO2011007292A1 (en) | 2009-07-13 | 2011-01-20 | Koninklijke Philips Electronics N.V. | Electro-physiological measurement with reduced motion artifacts |
US8626260B2 (en) | 2009-08-27 | 2014-01-07 | William Crosby | Expandable electrode pad |
US8475371B2 (en) | 2009-09-01 | 2013-07-02 | Adidas Ag | Physiological monitoring garment |
JP2013508029A (en) | 2009-10-15 | 2013-03-07 | マシモ コーポレイション | Acoustic respiration monitoring sensor having a plurality of detection elements |
WO2011050283A2 (en) | 2009-10-22 | 2011-04-28 | Corventis, Inc. | Remote detection and monitoring of functional chronotropic incompetence |
US9492096B2 (en) | 2009-11-03 | 2016-11-15 | Vivaquant Llc | ECG sensing apparatuses, systems and methods |
US8688202B2 (en) | 2009-11-03 | 2014-04-01 | Vivaquant Llc | Method and apparatus for identifying cardiac risk |
US9339202B2 (en) | 2009-11-03 | 2016-05-17 | Vivaquant Llc | System for processing physiological data |
US9414786B1 (en) | 2009-11-03 | 2016-08-16 | Vivaquant Llc | ECG sensing with noise filtering |
US8986207B2 (en) | 2009-11-12 | 2015-03-24 | Covidien Lp | Systems and methods for providing sensor arrays for detecting physiological characteristics |
US9451897B2 (en) | 2009-12-14 | 2016-09-27 | Medtronic Monitoring, Inc. | Body adherent patch with electronics for physiologic monitoring |
EP3150114B1 (en) | 2009-12-23 | 2022-11-09 | Braemar Manufacturing, LLC | Monitoring device for attachment to the skin surface |
US8874186B2 (en) | 2009-12-30 | 2014-10-28 | Avery Dennison Corporation | Apparatus and method for monitoring physiological parameters using electrical measurements |
US20110160601A1 (en) | 2009-12-30 | 2011-06-30 | Yang Wang | Wire Free Self-Contained Single or Multi-Lead Ambulatory ECG Recording and Analyzing Device, System and Method Thereof |
US11253159B2 (en) | 2010-01-31 | 2022-02-22 | Vladimir Shusterman | Tracking cardiac forces and arterial blood pressure using accelerometers |
US20110224556A1 (en) | 2010-03-10 | 2011-09-15 | Sotera Wireless, Inc. | Body-worn vital sign monitor |
US8467862B2 (en) | 2010-03-30 | 2013-06-18 | Pacesetter, Inc. | Systems and methods related to ST segment monitoring by an implantable medical device |
US8965498B2 (en) | 2010-04-05 | 2015-02-24 | Corventis, Inc. | Method and apparatus for personalized physiologic parameters |
WO2011129816A1 (en) | 2010-04-13 | 2011-10-20 | Empire Technology Development Llc | Semantic compression |
US20130041272A1 (en) | 2010-04-20 | 2013-02-14 | Wearable Information Technologies, S.L. (Weartech) | Sensor apparatus adapted to be incorporated in a garment |
EP3387991B1 (en) | 2010-05-12 | 2022-06-15 | Irhythm Technologies, Inc. | Device features and design elements for long-term adhesion |
BR112012029240A2 (en) | 2010-05-18 | 2017-05-30 | Zoll Medical Corp | ambulatory medical detection device with multiple detection electrodes |
US8594763B1 (en) | 2010-05-25 | 2013-11-26 | Neurowave Systems Inc. | Physiological electrode assembly for fast application |
US8565863B2 (en) | 2010-06-17 | 2013-10-22 | General Electric Company | ECG front end and method for acquiring ECG signals |
US8907782B2 (en) | 2010-06-30 | 2014-12-09 | Welch Allyn, Inc. | Medical devices with proximity detection |
US9055925B2 (en) | 2010-07-27 | 2015-06-16 | Carefusion 303, Inc. | System and method for reducing false alarms associated with vital-signs monitoring |
US20120029306A1 (en) | 2010-07-27 | 2012-02-02 | Carefusion 303, Inc. | Vital-signs monitor with encapsulation arrangement |
US9585620B2 (en) | 2010-07-27 | 2017-03-07 | Carefusion 303, Inc. | Vital-signs patch having a flexible attachment to electrodes |
US20120029300A1 (en) | 2010-07-27 | 2012-02-02 | Carefusion 303, Inc. | System and method for reducing false alarms and false negatives based on motion and position sensing |
US9615792B2 (en) | 2010-07-27 | 2017-04-11 | Carefusion 303, Inc. | System and method for conserving battery power in a patient monitoring system |
US9017255B2 (en) | 2010-07-27 | 2015-04-28 | Carefusion 303, Inc. | System and method for saving battery power in a patient monitoring system |
US9554725B2 (en) | 2010-08-03 | 2017-01-31 | Medtronic Monitoring, Inc. | Medical device and methods of monitoring a patient with renal dysfunction |
US8473047B2 (en) | 2010-08-03 | 2013-06-25 | Corventis, Inc. | Multifrequency bioimpedence device and related methods |
US8650045B2 (en) | 2010-09-02 | 2014-02-11 | Medical Management International, Inc. | Electronic health record sharing using hybrid architecture |
JP6087819B2 (en) | 2010-09-16 | 2017-03-01 | ニューロメトリックス・インコーポレーテッド | Single fully integrated handheld device |
US8585606B2 (en) | 2010-09-23 | 2013-11-19 | QinetiQ North America, Inc. | Physiological status monitoring system |
ES2922673T3 (en) | 2010-09-23 | 2022-09-19 | Bard Inc C R | Apparatus and method for catheter navigation using endovascular energy mapping |
US8613708B2 (en) | 2010-10-08 | 2013-12-24 | Cardiac Science Corporation | Ambulatory electrocardiographic monitor with jumpered sensing electrode |
US8285370B2 (en) | 2010-10-08 | 2012-10-09 | Cardiac Science Corporation | Microcontrolled electrocardiographic monitoring circuit with feedback control |
US20120089001A1 (en) | 2010-10-08 | 2012-04-12 | Jon Mikalson Bishay | Ambulatory Electrocardiographic Monitor And Method Of Use |
US20120089417A1 (en) | 2010-10-08 | 2012-04-12 | Bardy Gust H | Computer-Implemented System And Method For Mediating Patient-Initiated Physiological Monitoring |
US20120089000A1 (en) | 2010-10-08 | 2012-04-12 | Jon Mikalson Bishay | Ambulatory Electrocardiographic Monitor For Providing Ease Of Use In Women And Method Of Use |
USD639437S1 (en) | 2010-10-08 | 2011-06-07 | Cardiac Science Corporation | Wearable ambulatory electrocardiographic monitor |
US8239012B2 (en) | 2010-10-08 | 2012-08-07 | Cardiac Science Corporation | Microcontrolled electrocardiographic monitoring circuit with differential voltage encoding |
US9037477B2 (en) | 2010-10-08 | 2015-05-19 | Cardiac Science Corporation | Computer-implemented system and method for evaluating ambulatory electrocardiographic monitoring of cardiac rhythm disorders |
US20120089412A1 (en) | 2010-10-08 | 2012-04-12 | Bardy Gust H | Computer-Implemented System And Method For Facilitating Patient Advocacy Through Online Healthcare Provisioning |
US20120108993A1 (en) | 2010-10-27 | 2012-05-03 | Medtronic, Inc. | Electrode shapes and positions for reducing loss of contact in an implantable ecg recorder |
PL2640262T3 (en) | 2010-11-17 | 2015-12-31 | Smart Solutions Tech S L | Sensor for acquiring physiological signals |
US9808196B2 (en) | 2010-11-17 | 2017-11-07 | Smart Solutions Technologies, S.L. | Sensors |
EP2465415B1 (en) | 2010-12-20 | 2013-07-03 | General Electric Company | Single-use biomedical sensors |
US9375179B2 (en) | 2010-12-23 | 2016-06-28 | Biosense Webster, Inc. | Single radio-transparent connector for multi-functional reference patch |
US9775561B2 (en) | 2010-12-23 | 2017-10-03 | Covidien Lp | System method and device for monitoring physiological parameters of a person |
KR101747858B1 (en) | 2011-01-03 | 2017-06-16 | 삼성전자주식회사 | Electrode for living body and device for measuring living body signal |
WO2012094569A2 (en) | 2011-01-07 | 2012-07-12 | Access Business Group International Llc | Health monitoring system |
US8818260B2 (en) | 2011-01-14 | 2014-08-26 | Covidien, LP | Wireless relay module for remote monitoring systems |
GB2487758A (en) | 2011-02-03 | 2012-08-08 | Isansys Lifecare Ltd | Health monitoring electrode assembly |
GB201101858D0 (en) | 2011-02-03 | 2011-03-23 | Isansys Lifecare Ltd | Health monitoring |
US20120220835A1 (en) | 2011-02-14 | 2012-08-30 | Wayne Chung | Wireless physiological sensor system and method |
WO2012112186A1 (en) | 2011-02-15 | 2012-08-23 | The General Hospital Corporation | Systems and methods to monitor and quantify physiological stages |
EP2683994A4 (en) | 2011-03-09 | 2015-05-06 | Humetrix Com Inc | Mobile device-based system for automated, real time health record exchange |
US8909318B2 (en) | 2011-03-18 | 2014-12-09 | Nike Inc. | Apparel for physiological telemetry during athletics |
WO2012126503A1 (en) | 2011-03-18 | 2012-09-27 | St. Jude Medical Ab | Hemodynamic status assessment |
WO2012135028A1 (en) | 2011-03-25 | 2012-10-04 | Zoll Medical Corporation | Method of detecting signal clipping in a wearable ambulatory medical device |
US20120253847A1 (en) | 2011-03-31 | 2012-10-04 | General Electric Company | Health information telecommunications system and method |
US8818478B2 (en) | 2011-03-31 | 2014-08-26 | Adidas Ag | Sensor garment |
WO2012140559A1 (en) | 2011-04-11 | 2012-10-18 | Medic4All Ag | Pulse oximetry measurement triggering ecg measurement |
US20120265080A1 (en) | 2011-04-15 | 2012-10-18 | Xiong Yu | Non-contact sensing of physiological signals |
EP2696750B1 (en) | 2011-04-15 | 2016-08-10 | Infobionic, Inc. | Remote data monitoring and collection system with multi-tiered analysis |
WO2012145652A1 (en) * | 2011-04-20 | 2012-10-26 | Trustees Of Tufts College | Dynamic silk coatings for implantable devices |
JP5998202B2 (en) | 2011-04-29 | 2016-09-28 | コーニンクレッカ フィリップス エヌ ヴェKoninklijke Philips N.V. | Apparatus used for fall detector or fall detection system and method for operating the apparatus |
US8773258B2 (en) | 2011-06-06 | 2014-07-08 | Halthion Medical Technologies, Inc. | Data collection module for a physiological data collection system |
US8554311B2 (en) | 2011-06-17 | 2013-10-08 | General Electric Company | System and method of noise reduction in an electrocardiology study |
US20130087609A1 (en) | 2011-06-17 | 2013-04-11 | The University of Washington through its Center for Commercialization, a public Institution of Hig | Medical Device Tracking System and Method |
US20130124891A1 (en) | 2011-07-15 | 2013-05-16 | Aliphcom | Efficient control of power consumption in portable sensing devices |
US8726496B2 (en) | 2011-09-22 | 2014-05-20 | Covidien Lp | Technique for remanufacturing a medical sensor |
US9220436B2 (en) | 2011-09-26 | 2015-12-29 | Covidien Lp | Technique for remanufacturing a BIS sensor |
US9119594B2 (en) | 2011-09-27 | 2015-09-01 | Under Armour, Inc. | Electronic housing and sensor connection arrangement |
US9247907B2 (en) | 2011-09-27 | 2016-02-02 | Under Armour, Inc. | Garment with receptacle and electronic module |
US9668668B2 (en) | 2011-09-30 | 2017-06-06 | Medtronic, Inc. | Electrogram summary |
EP2589333A1 (en) | 2011-11-04 | 2013-05-08 | BIOTRONIK SE & Co. KG | Apparatus and system for long-term cutaneous cardiac monitoring |
US8996109B2 (en) * | 2012-01-17 | 2015-03-31 | Pacesetter, Inc. | Leadless intra-cardiac medical device with dual chamber sensing through electrical and/or mechanical sensing |
US9668804B2 (en) | 2011-11-11 | 2017-06-06 | Massachusetts Institute Of Technology | Automated cell patch clamping method and apparatus |
EP2775915B1 (en) | 2011-11-11 | 2018-12-05 | National University of Ireland Galway | Apparatus for prevention of syncope |
US9700222B2 (en) | 2011-12-02 | 2017-07-11 | Lumiradx Uk Ltd | Health-monitor patch |
US8606351B2 (en) | 2011-12-28 | 2013-12-10 | General Electric Company | Compression of electrocardiograph signals |
EP2802256A2 (en) | 2012-01-10 | 2014-11-19 | The Regents of The University of Michigan | Atrial fibrillation classification using power measurement |
US10034614B2 (en) | 2012-02-29 | 2018-07-31 | General Electric Company | Fractional flow reserve estimation |
US9427165B2 (en) | 2012-03-02 | 2016-08-30 | Medtronic Monitoring, Inc. | Heuristic management of physiological data |
US20140214134A1 (en) | 2012-03-12 | 2014-07-31 | Valencia Technologies Corporation | Closed Loop Chronic Electroacupuncture System Using Changes in Body Temperature or Impedance |
TWI494081B (en) | 2012-03-16 | 2015-08-01 | Univ Nat Cheng Kung | Electrocardiogram signal compression and de-compression system |
WO2013144617A1 (en) | 2012-03-30 | 2013-10-03 | Lifescan Scotland Limited | Battery status detection and storage method and system in medical monitoring |
WO2013155503A1 (en) | 2012-04-13 | 2013-10-17 | Langer Alois A | Outpatient health emergency warning system |
US9277864B2 (en) | 2012-05-24 | 2016-03-08 | Vital Connect, Inc. | Modular wearable sensor device |
US20130324809A1 (en) | 2012-05-31 | 2013-12-05 | Nellcor Puritan Bennett Llc | Methods and systems for power optimization in a medical device |
US9241643B2 (en) | 2012-05-31 | 2016-01-26 | Covidien Lp | Methods and systems for power optimization in a medical device |
US9241676B2 (en) | 2012-05-31 | 2016-01-26 | Covidien Lp | Methods and systems for power optimization in a medical device |
US10650917B2 (en) | 2012-07-02 | 2020-05-12 | Carefusion 303, Inc. | Patient-device association system |
EP2877236B1 (en) | 2012-07-26 | 2023-03-29 | Medtronic, Inc. | Implantable medical leads |
US9258389B2 (en) | 2012-08-13 | 2016-02-09 | Gurulogic Microsystems Oy | Encoder and method |
US20140056452A1 (en) | 2012-08-21 | 2014-02-27 | Analog Devices, Inc. | Portable Device with Power Management Controls |
US8945328B2 (en) | 2012-09-11 | 2015-02-03 | L.I.F.E. Corporation S.A. | Methods of making garments having stretchable and conductive ink |
EP2710953B1 (en) | 2012-09-21 | 2015-03-04 | BIOTRONIK SE & Co. KG | Method of enhancing the signal-to-noise ratio (SNR) of measured electrocardiogram (ECG) signals and a cardiac device for use in detecting heartbeats |
US9392949B2 (en) | 2012-10-02 | 2016-07-19 | Xsynchro, Inc. | Ventricular pacing in cardiac-related applications |
US20140107509A1 (en) | 2012-10-08 | 2014-04-17 | Perminova Inc | Internet-based system for collecting and analyzing data before, during, and after a cardiovascular procedure |
BR112015008090A2 (en) | 2012-10-12 | 2017-07-04 | Delta Dansk Elektronik Lys Og Akustik | monitoring device and method for manufacturing a device |
WO2014071079A1 (en) | 2012-10-31 | 2014-05-08 | The Board Of Trustees Of The Leland Stanford Junior University | Wireless implantable sensing devices |
KR101759806B1 (en) | 2012-11-01 | 2017-07-19 | 블루 스파크 테크놀러지스, 인크. | Body temperature logging patch |
WO2014080403A1 (en) | 2012-11-24 | 2014-05-30 | Healthwatch Ltd. | Vertical conductive textile traces and methods of knitting thereof |
US9282911B2 (en) | 2012-11-27 | 2016-03-15 | Physio-Control, Inc. | Linear display of ECG signals |
US20140180027A1 (en) | 2012-12-20 | 2014-06-26 | U.S. Government, As Represented By The Secretary Of The Army | Estimation of Human Core Temperature based on Heart Rate System and Method |
US8948935B1 (en) | 2013-01-02 | 2015-02-03 | Google Inc. | Providing a medical support device via an unmanned aerial vehicle |
US8620418B1 (en) | 2013-01-04 | 2013-12-31 | Infobionic, Inc. | Systems and methods for processing and displaying patient electrocardiograph data |
WO2014107700A1 (en) | 2013-01-07 | 2014-07-10 | Alivecor, Inc. | Methods and systems for electrode placement |
AU2014209376B2 (en) | 2013-01-24 | 2017-03-16 | Irhythm Technologies, Inc. | Physiological monitoring device |
CA2897791A1 (en) | 2013-01-25 | 2014-07-31 | Vanderbilt Universtiy | Smart mobile health monitoring system and related methods |
US9146605B2 (en) | 2013-01-31 | 2015-09-29 | Salutron, Inc. | Ultra low power actigraphy based on dynamic threshold |
US9298882B2 (en) | 2013-03-04 | 2016-03-29 | Hello Inc. | Methods using patient monitoring devices with unique patient IDs and a telemetry system |
US20140296651A1 (en) | 2013-04-01 | 2014-10-02 | Robert T. Stone | System and Method for Monitoring Physiological Characteristics |
US9993199B2 (en) | 2013-04-10 | 2018-06-12 | Omsignal Inc. | Textile blank with seamless knitted electrode system |
US10251573B2 (en) | 2013-05-03 | 2019-04-09 | Medtronic, Inc. | Electrogram summary |
WO2014194691A1 (en) | 2013-06-07 | 2014-12-11 | 北京丰拓生物技术有限公司 | Card type electrocardiogram measurement device |
US20150018660A1 (en) | 2013-07-11 | 2015-01-15 | Alivecor, Inc. | Apparatus for Coupling to Computing Devices and Measuring Physiological Data |
WO2015030712A1 (en) | 2013-08-26 | 2015-03-05 | Bodhi Technology Ventures Llc | Method of detecting the wearing limb of a wearable electronic device |
KR101536139B1 (en) | 2013-09-05 | 2015-07-13 | 연세대학교 산학협력단 | Textile electrode kit, and the motion artifact-minimizing clothing installed with the kit |
US9615763B2 (en) | 2013-09-25 | 2017-04-11 | Bardy Diagnostics, Inc. | Ambulatory electrocardiography monitor recorder optimized for capturing low amplitude cardiac action potential propagation |
US9700227B2 (en) | 2013-09-25 | 2017-07-11 | Bardy Diagnostics, Inc. | Ambulatory electrocardiography monitoring patch optimized for capturing low amplitude cardiac action potential propagation |
US9730593B2 (en) | 2013-09-25 | 2017-08-15 | Bardy Diagnostics, Inc. | Extended wear ambulatory electrocardiography and physiological sensor monitor |
US9717433B2 (en) | 2013-09-25 | 2017-08-01 | Bardy Diagnostics, Inc. | Ambulatory electrocardiography monitoring patch optimized for capturing low amplitude cardiac action potential propagation |
US9408551B2 (en) | 2013-11-14 | 2016-08-09 | Bardy Diagnostics, Inc. | System and method for facilitating diagnosis of cardiac rhythm disorders with the aid of a digital computer |
US20150094559A1 (en) | 2013-09-27 | 2015-04-02 | Covidien Lp | Modular physiological sensing patch |
WO2015072984A1 (en) | 2013-11-13 | 2015-05-21 | Empire Technology Development Llc | Dispatch of automated external defibrillators |
EP3079571A4 (en) | 2013-12-12 | 2017-08-02 | Alivecor, Inc. | Methods and systems for arrhythmia tracking and scoring |
US9220903B2 (en) | 2013-12-16 | 2015-12-29 | AtCor Medical Pty, Ltd. | Optimization of pacemaker settings with R-wave detection |
US9500616B2 (en) | 2013-12-23 | 2016-11-22 | Cilag Gmbh International | Multi-orientation test strip |
US20150324690A1 (en) | 2014-05-08 | 2015-11-12 | Microsoft Corporation | Deep Learning Training System |
EP3157417B1 (en) | 2014-06-17 | 2022-04-13 | The University of Virginia Patent Foundation | System and method for improved cardiac rhythm classification from time between heart beat intervals using non-linear dynamics |
US20180116537A1 (en) * | 2014-07-07 | 2018-05-03 | Zoll Medical Corporation | System and Method for Distinguishing a Cardiac Event From Noise in an Electrocardiogram (ECG) Signal |
US9636505B2 (en) | 2014-11-24 | 2017-05-02 | AtaCor Medical, Inc. | Cardiac pacing sensing and control |
KR102335784B1 (en) | 2014-10-31 | 2021-12-06 | 아이리듬 테크놀로지스, 아이엔씨 | Wireless physiological monitoring device and systems |
US10350417B2 (en) * | 2014-11-26 | 2019-07-16 | Medtronic, Inc. | Atrial synchronized ventricular pacing system using intracardiac pacemaker and extracardiac atrial sensing |
CA2872754A1 (en) | 2014-12-02 | 2016-06-02 | Carre Technologies Inc. | Low-power respiratory inductance plethysmography device, intelligent garments or wearable items equipped therewith and a method for respiratory activity analysis |
IL236598A0 (en) | 2015-01-05 | 2015-05-31 | Superfish Ltd | Image similarity as a function of weighted descriptor similarities derived from neural networks |
US10223635B2 (en) | 2015-01-22 | 2019-03-05 | Qualcomm Incorporated | Model compression and fine-tuning |
US9901276B2 (en) * | 2015-02-18 | 2018-02-27 | Medtronic, Inc. | Method and apparatus for identifying sick sinus syndrome in an implantable cardiac monitoring device |
US9949714B2 (en) | 2015-07-29 | 2018-04-24 | Htc Corporation | Method, electronic apparatus, and computer readable medium of constructing classifier for disease detection |
US11154228B2 (en) | 2015-08-31 | 2021-10-26 | Zoll Medical Corporation | Electrode use indication |
US20170065207A1 (en) | 2015-09-06 | 2017-03-09 | Cardiac Pacemakers, Inc. | Antennas for small imds |
EP3346900A4 (en) | 2015-09-08 | 2019-05-01 | Rose, Robert Howard | Integrated medical device and home based system to measure and report vital patient physiological data via telemedicine |
DK3367897T3 (en) | 2015-10-27 | 2021-05-31 | Cardiologs Tech | AN AUTOMATIC PROCEDURE TO DEFINE OR CATEGORIZE AN ELECTROCARDIOGRAM |
US10426364B2 (en) | 2015-10-27 | 2019-10-01 | Cardiologs Technologies Sas | Automatic method to delineate or categorize an electrocardiogram |
FR3043902B1 (en) | 2015-11-19 | 2018-02-23 | @Health | METHOD AND SYSTEM FOR ACQUIRING AND ANALYZING PHYSIOLOGICAL DATA |
US20170156592A1 (en) | 2015-12-02 | 2017-06-08 | Mediatek Inc. | Healthcare systems and monitoring method for physiological signals |
US10779767B2 (en) | 2016-08-10 | 2020-09-22 | Pacesetter, Inc. | Antenna for an implantable cardiac monitoring device |
KR102631381B1 (en) | 2016-11-07 | 2024-01-31 | 삼성전자주식회사 | Convolutional neural network processing method and apparatus |
US10987517B2 (en) | 2017-03-15 | 2021-04-27 | Medtronic, Inc. | Detection of noise signals in cardiac signals |
WO2019030746A1 (en) | 2017-08-10 | 2019-02-14 | Zoll Medical Israel Ltd. | Systems, devices and methods for physiological monitoring of patients |
US10602942B2 (en) | 2017-08-25 | 2020-03-31 | Cambridge Heartwear Limited | Method of detecting abnormalities in ECG signals |
US11013436B2 (en) | 2017-09-06 | 2021-05-25 | Medtronic, Inc. | Marker monitoring via a medical device |
WO2019073288A1 (en) | 2017-10-12 | 2019-04-18 | Gushev Marjan | Remote ecg monitoring and alerting methods and sensing device |
-
2017
- 2017-12-05 US US15/832,385 patent/US20190167139A1/en not_active Abandoned
-
2018
- 2018-12-03 EP EP18209920.0A patent/EP3494871A1/en not_active Ceased
-
2022
- 2022-03-03 US US17/686,335 patent/US11678830B2/en active Active
Patent Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7294108B1 (en) * | 2005-01-27 | 2007-11-13 | Pacesetter, Inc. | Cardiac event microrecorder and method for implanting same |
US20090012412A1 (en) * | 2005-02-25 | 2009-01-08 | Joseph Wiesel | Detecting Atrial Fibrillation, Method of and Apparatus for |
US8108035B1 (en) * | 2006-10-18 | 2012-01-31 | Pacesetter, Inc. | Systems and methods for detecting and compensating for changes in posture during ischemia detection a using an implantable medical device |
US9345414B1 (en) * | 2013-09-25 | 2016-05-24 | Bardy Diagnostics, Inc. | Method for providing dynamic gain over electrocardiographic data with the aid of a digital computer |
US20170112399A1 (en) * | 2015-10-23 | 2017-04-27 | Cardiac Pacemakers, Inc. | Multi-vector sensing in cardiac devices using a hybrid approach |
US20170281032A1 (en) * | 2016-03-29 | 2017-10-05 | Pacestter, Inc. | Method and system to discriminate rhythm patterns in cardiac activity |
US20170281033A1 (en) * | 2016-03-30 | 2017-10-05 | Medtronic, Inc. | Atrial arrhythmia episode detection in a cardiac medical device |
US20170366921A1 (en) * | 2016-05-20 | 2017-12-21 | Pacesetter, Inc. | Dynamic Announcing For Creation Of Wireless Communication Connections |
US20170354365A1 (en) * | 2016-06-13 | 2017-12-14 | Medtronic, Inc. | Multi-parameter prediction of acute cardiac episodes and attacks |
US20180078771A1 (en) * | 2016-09-21 | 2018-03-22 | Cardiac Pacemakers, Inc. | Implantable cardiac monitor |
US20190336032A1 (en) * | 2018-05-07 | 2019-11-07 | Pacesetter, Inc. | Method and system to detect premature ventricular contractions in cardiac activity signals |
US20200038671A1 (en) * | 2018-07-31 | 2020-02-06 | Medtronic, Inc. | Wearable defibrillation apparatus configured to apply a machine learning algorithm |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USD957639S1 (en) * | 2013-03-15 | 2022-07-12 | Medtronic, Inc. | Implantable cardiac monitor |
USD997360S1 (en) | 2013-03-15 | 2023-08-29 | Medtronic, Inc. | Implantable cardiac monitor |
USD997361S1 (en) | 2013-03-15 | 2023-08-29 | Medtronic, Inc. | Implantable cardiac monitor |
USD1029269S1 (en) | 2013-03-15 | 2024-05-28 | Medtronic, Inc. | Implantable cardiac monitor |
USD926989S1 (en) * | 2018-02-19 | 2021-08-03 | Socrates Health Solutions, Inc. | Pen device |
US11116451B2 (en) * | 2019-07-03 | 2021-09-14 | Bardy Diagnostics, Inc. | Subcutaneous P-wave centric insertable cardiac monitor with energy harvesting capabilities |
US20210401371A1 (en) * | 2019-07-03 | 2021-12-30 | Bardy Diagnostics, Inc. | System for cardiac monitoring with energy-harvesting-enhanced data transfer capabilities |
US11653880B2 (en) * | 2019-07-03 | 2023-05-23 | Bardy Diagnostics, Inc. | System for cardiac monitoring with energy-harvesting-enhanced data transfer capabilities |
WO2021030216A1 (en) | 2019-08-09 | 2021-02-18 | Bardy Diagnostics, Inc. | Facilitating a cardiac rhythm disorder diagnosis with the aid of a digital computer |
US20220061742A1 (en) * | 2020-08-28 | 2022-03-03 | Covidien Lp | Determining composite signals from at least three electrodes |
EP4027620A1 (en) | 2021-01-10 | 2022-07-13 | Bardy Diagnostics, Inc. | System and method for long-term patient monitoring of continuous ecg and physiological data |
US20230106359A1 (en) * | 2021-09-24 | 2023-04-06 | Biointellisense, Inc. | Multi-use ecg system |
Also Published As
Publication number | Publication date |
---|---|
US11678830B2 (en) | 2023-06-20 |
EP3494871A1 (en) | 2019-06-12 |
US20220183603A1 (en) | 2022-06-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11653870B2 (en) | System and method for display of subcutaneous cardiac monitoring data | |
US11678830B2 (en) | Noise-separating cardiac monitor | |
US11445962B2 (en) | Ambulatory electrocardiography monitor | |
US11678798B2 (en) | System and method for remote ECG data streaming in real-time | |
US11653868B2 (en) | Subcutaneous insertable cardiac monitor optimized for electrocardiographic (ECG) signal acquisition | |
US11653880B2 (en) | System for cardiac monitoring with energy-harvesting-enhanced data transfer capabilities | |
US11660035B2 (en) | Insertable cardiac monitor | |
US11963780B2 (en) | System for coil-based implantable physiological monitor energy transmission | |
US11794020B2 (en) | System and method for data exchange and charging | |
EP3770916A1 (en) | System and method for remote ecg data streaming in real-time |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: BARDY DIAGNOSTICS, INC., WASHINGTON Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BARDY, GUST H.;REEL/FRAME:046254/0781 Effective date: 20180525 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
AS | Assignment |
Owner name: JPMORGAN CHASE BANK, N.A., ILLINOIS Free format text: SECURITY AGREEMENT SUPPLEMENT;ASSIGNOR:BARDY DIAGNOSTICS, INC.;REEL/FRAME:058567/0677 Effective date: 20211022 |
|
AS | Assignment |
Owner name: HILL-ROM HOLDINGS, INC., ILLINOIS Free format text: RELEASE OF SECURITY INTEREST (SENT FOR RECORDAL OCTOBER 25, 2021);ASSIGNOR:JPMORGAN CHASE BANK, N.A.;REEL/FRAME:058516/0312 Effective date: 20211213 Owner name: BARDY DIAGNOSTICS, INC., ILLINOIS Free format text: RELEASE OF SECURITY INTEREST (SENT FOR RECORDAL OCTOBER 25, 2021);ASSIGNOR:JPMORGAN CHASE BANK, N.A.;REEL/FRAME:058516/0312 Effective date: 20211213 Owner name: VOALTE, INC., FLORIDA Free format text: RELEASE OF SECURITY INTEREST (SENT FOR RECORDAL OCTOBER 25, 2021);ASSIGNOR:JPMORGAN CHASE BANK, N.A.;REEL/FRAME:058516/0312 Effective date: 20211213 Owner name: HILL-ROM, INC., ILLINOIS Free format text: RELEASE OF SECURITY INTEREST (SENT FOR RECORDAL OCTOBER 25, 2021);ASSIGNOR:JPMORGAN CHASE BANK, N.A.;REEL/FRAME:058516/0312 Effective date: 20211213 Owner name: WELCH ALLYN, INC., NEW YORK Free format text: RELEASE OF SECURITY INTEREST (SENT FOR RECORDAL OCTOBER 25, 2021);ASSIGNOR:JPMORGAN CHASE BANK, N.A.;REEL/FRAME:058516/0312 Effective date: 20211213 Owner name: ALLEN MEDICAL SYSTEMS, INC., ILLINOIS Free format text: RELEASE OF SECURITY INTEREST (SENT FOR RECORDAL OCTOBER 25, 2021);ASSIGNOR:JPMORGAN CHASE BANK, N.A.;REEL/FRAME:058516/0312 Effective date: 20211213 Owner name: HILL-ROM SERVICES, INC., ILLINOIS Free format text: RELEASE OF SECURITY INTEREST (SENT FOR RECORDAL OCTOBER 25, 2021);ASSIGNOR:JPMORGAN CHASE BANK, N.A.;REEL/FRAME:058516/0312 Effective date: 20211213 Owner name: BREATHE TECHNOLOGIES, INC., CALIFORNIA Free format text: RELEASE OF SECURITY INTEREST (SENT FOR RECORDAL OCTOBER 25, 2021);ASSIGNOR:JPMORGAN CHASE BANK, N.A.;REEL/FRAME:058516/0312 Effective date: 20211213 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |